Movement is medicine — but only when we understand the physiology behind it.
I'm Mandeepa Kumawat, a physical therapist and research exercise physiologist with a focus on cardiopulmonary function, exercise capacity, and the role of targeted physical stress in rehabilitation and long-term health. My work sits at the intersection of clinical practice and human science — translating evidence from CPET, cardiovascular research, and exercise intervention into frameworks that actually change how we treat and train patients.
Whether you're a clinician, a researcher, or a student building your foundation, this space is where I share what the data says — and what it means for the people in front of us.
Most people focus on what the numbers mean. The real skill lies in how you think while the test is happening — a 7-step mindset framework for cardiopulmonary exercise testing.
The heart gets the whole lecture. But the skeletal muscle pump decides what arrives, and the diaphragm decides how much the legs are allowed to keep.
August 13, 2026 · 12 min read
Wearables
48 on Your Watch, 41 on the Cart
No smartwatch measures oxygen. Two different algorithm families produce that number, they disagree by up to 10 mL/kg/min, and the error is largest exactly where clinical interest lives.
August 7, 2026 · 11 min read
Wearables
Your Watch Doesn't See Your Heart. It Sees Light.
Photoplethysmography extracts a dozen metrics from roughly 1% of an optical signal. A guide to how PPG works, why the wear site beats the brand, and how to tell a wearable measurement from a wearable prediction.
August 6, 2026 · 9 min read
Career
I Missed Medical School by 2 Marks. Here's Every Path That Opened Instead.
A map of the forks, the options I turned down at each one, and how a missed cutoff led to running cardiopulmonary exercise tests for a living.
July 29, 2026 · 8 min read
CPET
VO2peak vs VO2max: The One-Letter Difference Your Report Can't Fudge
Same units, same machine — but only one of these labels makes a promise your data has to earn. Where to spot it on the printout, the 5 variables that separate them, and how plateau odds shift across the lifespan.
July 19, 2026 · 6 min read
CPET
Peak VO2 Is Just the Beginning
Same peak VO2 on the report. Eight different ways to read it — and eight different physiological stories depending on which lens you use.
July 16, 2026 · 7 min read
CPET
The Four-Minute Rule: Why the Norwegian 4×4 Is the Gold Standard for VO₂max
Four hard minutes, three easy, repeated four times. It looks almost too simple — but every number in the protocol is solving a precise physiological problem rooted in the Fick equation.
June 10, 2026 · 6 min read
CPET
Treadmill vs. Cycle Ergometer: The Modality Is the Question
The equipment you pick quietly shapes what your CPET data means — which system reaches its ceiling first, and which question your test can actually answer.
June 2, 2026 · 6 min read
CPET
Your Body's Hidden Report Card: What Autonomic Regulation Really Looks Like
CPET and REE numbers quietly reveal how well your autonomic nervous system is regulating your entire body — here's what to look for.
May 3, 2026 · 6 min read
CPET
Panel 7: The Breath at the End — What PₑₜO₂ and PₑₜCO₂ Quietly Reveal
End-tidal gas pressures are a non-invasive window into ventilation-perfusion matching. Here's how to read the story they're telling.
May 5, 2026 · 7 min read
Career
Research vs. Clinical Exercise Physiologist: Two Paths, One Mission
Most people think all exercise physiologists do the same work. Here's what really separates the two paths — and what a day in research actually looks like.
May 3, 2026 · 5 min read
CPET
Wasserman 9-Panel Plot — Panel 1: Six Things Most Clinicians Miss
Most clinicians look at peak VO₂ and move on. But Panel 1 of a CPET has 6 things worth reading — and most of them get missed.
May 3, 2026 · 6 min read
CPET
Wasserman 9-Panel Plot — Panel 2: Beyond Peak VO₂
O₂ pulse and heart rate kinetics: how the relationship between HR and oxygen delivery reveals the true mechanism behind exercise limitation.
May 8, 2026 · 6 min read
CPET
Wasserman 9-Panel Plot — Panel 3: Reading Between the HR Lines
HR doesn't just rise during exercise — it rises relative to VO₂. Panel 3 reveals if the heart is doing too much, too little, or just right.
May 10, 2026 · 6 min read
CPET
Wasserman 9-Panel Plot — Panel 5: Balancing Breathing and Work
Panel 5 tracks the relationship between Minute Ventilation and Work Rate. It is the primary tool for assessing if a patient's breathing is appropriate for their effort.
May 12, 2026 · 6 min read
CPET
Wasserman 9-Panel Plot — Panel 8: The Effort Validator
RER ≥ 1.10 confirms maximal effort — but the shape of the curve tells a far richer story about fuel use, anaerobic threshold, and cardiopulmonary integrity.
May 18, 2026 · 8 min read
CPET
Panel 9: VT vs. V̇E — The Breathing Pattern Plot Most Labs Gloss Over
Most labs glance at this one and move on. But the VT vs V̇E plot tells you how a patient is compensating — and that distinction matters clinically.
May 18, 2026 · 7 min read
CPET
Beyond the Mask: What Invasive CPET Reveals That Non-Invasive Testing Cannot
Standard CPET treats the cardiovascular system as a black box. Invasive CPET opens it — directly measuring cardiac output, pulmonary pressures, and true Fick equation variables.
May 27, 2026 · 8 min read
CPET
Your ANS is the maestro of CPET—here's how it conducts from rest to recovery
When you're watching a patient on a metabolic cart during a maximal incremental CPET, you aren't looking at gas exchange — you're watching a literal tug-of-war between the parasympathetic and sympathetic nervous systems.
June 29, 2026 · 10 min read
CPET
VO2 Kinetics: What the Rise Tells You Before the Peak Does
VO2peak tells you the ceiling. Kinetics tell you how efficiently a patient gets there — and that shape carries clinical information the peak value alone can't.
July 11, 2026 · 6 min read
CPET
Reading the Wasserman 9-Panel Plot in Children: Why Kids Aren't Small Adults
Nine graphs, one story — and a grammar that's genuinely different in paediatrics. Includes an interactive walkthrough of a full pediatric CPET from rest to recovery.
July 25, 2026 · 9 min read
📅 Events
Conferences, Congresses & Seminars
A curated, regularly updated calendar of meetings relevant to cardiopulmonary exercise testing (CPET), clinical and applied exercise physiology, cardiology, pulmonology, and sport science — useful for clinicians, researchers, and students. Dates and links are verified against official society pages; entries with TBA dates are confirmed to recur.
United States & North America
Aug05
Pediatric Exercise Medicine · Biennial Meeting
NASPEM 2026 Biennial Meeting
📍 University of Illinois Discovery Partners Institute, Chicago, IL🕒 Aug 5–8, 2026
For: pediatric exercise physiologists, researchers, and clinicians working in child/adolescent exercise science
The flagship meeting of the North American Society for Pediatric Exercise Medicine, bringing together international experts in pediatric exercise science, clinical practice, and child health research — directly relevant for CPET work in pediatric oncology and other pediatric clinical populations.
The most directly CPET-focused course on this list. Run by Mayo Clinic (directors Scott A. Helgeson, MD and Bryan J. Taylor, PhD), it covers cardiopulmonary exercise tests, pulmonary function tests, submaximal stress testing, and impulse oscillometry, with strong emphasis on interpretation across diverse patient scenarios. Optional live demonstrations include a standard ramp-incremental CPET with dynamic inspiratory-capacity assessment described in real time, plus a live clinical PFT walkthrough. Offered in person and via livestream.
For: clinical exercise physiologists, cardiac/pulmonary rehab teams, students
The premier U.S. gathering of cardiovascular and pulmonary rehabilitation professionals, hosted by the American Association of Cardiovascular and Pulmonary Rehabilitation. Programming sits squarely within clinical exercise physiology practice — exercise prescription, risk stratification, secondary prevention, and program operations — making it one of the most career-relevant meetings for CEPs working in rehab settings.
📍 Phoenix Convention Center, Phoenix, AZ🕒 Oct 18–21, 2026
For: pulmonologists, critical care & sleep clinicians, respiratory researchers
A comprehensive chest-medicine program spanning pulmonary, critical care, and sleep medicine, with extensive hands-on simulation, interactive case sessions, and original research presentations. Relevant to CPET work through its coverage of dyspnea evaluation, pulmonary vascular disease, and exercise limitation in respiratory conditions.
MGC Diagnostics — one of the original sponsors of the Wasserman/Whipp CPET Practicum tradition — runs its own 3-day Cardiorespiratory Diagnostics Seminar covering CPET, PFT, and metabolic testing. The fall 2026 edition is scheduled for Las Vegas. Strong hands-on component with equipment demonstrations; particularly relevant for lab staff and clinicians involved in day-to-day CPET operations and QC.
3rd International Pediatric Cardio-Oncology Conference
📍 The Westin, Cincinnati, OH🕒 Oct 23–24, 2026 (welcome reception Oct 22)
For: pediatric cardiologists, cardio-oncology researchers, exercise physiologists working in oncology settings
Hosted by the Pediatric Cardio-Oncology Consortium with Cincinnati Children's, Sofia's Hope, and the Pediatric Cardiomyopathy Registry, endorsed by the International Cardio-Oncology Society. The 2026 program includes a session on practical exercise prescription for patients treated for childhood cancer, sitting squarely within pediatric CPET and exercise oncology practice.
📍 The Lundquist Institute, Torrance, CA🕒 Oct 29–31, 2026
For: physicians, exercise scientists, and laboratory personnel involved in CPET
The original CPET practicum, inaugurated in 1982 by Drs. Karlman Wasserman and Brian J. Whipp and still run by the same division at Harbor-UCLA, now under course director Kathy E. Sietsema, MD. Three days of didactic lectures, laboratory demonstrations, and hands-on interpretation practice built around the Wasserman 9-panel framework. Registration limited to 20 participants; offered roughly three times a year.
AHA Scientific Sessions 2026 — American Heart Association
📍 McCormick Place, Chicago, IL🕒 Nov 6–9, 2026
For: cardiologists, cardiovascular researchers, allied health, students
The AHA's flagship meeting and one of the largest cardiovascular science gatherings in the world. Features late-breaking clinical trials, translational and basic science, and implementation programming. Strong relevance for those working at the intersection of exercise capacity, heart failure, and cardiovascular outcomes.
AARC Congress 2026 — American Association for Respiratory Care
📍 New Orleans Convention Center, New Orleans, LA🕒 Nov 14–17, 2026
For: respiratory therapists, pulmonary diagnostics and PFT lab staff, educators, students
The largest annual gathering of respiratory care professionals in the U.S., with a dedicated pulmonary function track alongside adult acute care, neonatal/pediatric, education, and research programming. Practical value for anyone running a cardiopulmonary diagnostics lab — equipment, quality control, and testing standards feature heavily in both sessions and the exhibit hall. Housing opens mid-August 2026.
The flagship meeting of the Clinical Exercise Physiology Association, an ACSM affiliate society — arguably the most field-specific event for a clinical EP. The online format covers practical translation of research across topics such as exercise oncology and treatment-related side effects, sarcopenia/frailty, peripheral artery disease, LVAD in rehabilitation, AI and technology, and gestational diabetes. ACSM-approved CECs; recordings provided to registrants. Member-friendly pricing (student rates available).
ACSM's regional chapters host accessible annual meetings that are ideal for students and junior investigators to present work and build their network. The Texas chapter (TACSM) is a strong example, with named lectures spanning pulmonary physiology, cardiovascular physiology, and exercise — plus a student career panel and the popular Student Bowl. The 2026 TACSM meeting ran Feb 26–27 at the Waco Convention Center; 2027 dates have not been posted yet. Check your regional chapter for the nearest meeting.
APS’s flagship annual meeting, spanning basic, translational, and integrative physiology, and the society’s main venue for exercise physiology work now that the standalone Integrative Physiology of Exercise conference runs only every four years (last held 2024). Strong trainee programming, poster receptions, and career development sessions.
ACC's annual scientific session, held jointly with the World Congress of Cardiology. A major venue for clinical cardiology updates, late-breaking trials, and guideline-shaping science. Exclusive member registration opens Oct 14, 2026, with general early-bird registration running Oct 28 – Dec 2, 2026.
ATS 2027 — American Thoracic Society International Conference
📍 Ernest N. Morial Convention Center, New Orleans, LA🕒 May 14–19, 2027
For: pulmonologists, critical care & sleep clinicians, researchers, nurses
A major multidisciplinary respiratory meeting with substantial overlap into exercise physiology — dyspnea, gas exchange, pulmonary vascular disease, and exercise limitation are recurring themes, making it valuable for CPET-focused practice and research.
Sports Medicine & Exercise Science · Annual Meeting · 2027
ACSM 74th Annual Meeting — American College of Sports Medicine
📍 Indiana Convention Center & Lucas Oil Stadium, Indianapolis, IN🕒 Jun 1–4, 2027
For: exercise physiologists, sports medicine clinicians, researchers, students
ACSM's flagship annual meeting and the largest general gathering in exercise science — spanning basic, applied, and clinical research across the full breadth of the field, including CPET-adjacent programming in cardiovascular and clinical exercise physiology.
Paediatric Sport and Exercise Medicine — Utrecht Summer School
📍 Utrecht Science Park, Utrecht, The Netherlands🕒 Aug 17–21, 2026
For: students (Ba, Ma, PhD) and professionals in sport or health care
A week-long, face-to-face introduction to paediatric sport and exercise medicine (course code M20; 1.5 ECTS), directed by Tim Takken, PhD, of the Child Exercise Center at Wilhelmina Children's Hospital (UMC Utrecht). The programme covers the clinical application of exercise testing in healthy children and those with chronic conditions, with hands-on demonstrations of cardiopulmonary exercise testing, field fitness testing, and body composition. Registration for the 2026 edition has now closed; the course runs annually each August.
ESC Congress 2026 — European Society of Cardiology
📍 Messe München / ICM, Munich, Germany🕒 Aug 28–31, 2026
For: cardiologists, researchers, allied health professionals
The world's foremost cardiology congress, drawing roughly 30,000 attendees. The 2026 edition spotlights artificial intelligence in cardiovascular care. Vast programming includes preventive and sports cardiology streams relevant to exercise testing and rehabilitation.
ERS Congress 2026 — European Respiratory Society (36th)
📍 Fira Gran Via, Barcelona, Spain🕒 Sep 5–9, 2026
For: pulmonologists, respiratory scientists, allied health
The largest respiratory-medicine meeting in the world. The 2026 theme — "United for better breathing: partnership between patients, clinicians and researchers" — reflects a strong translational focus, with sessions on exercise limitation, pulmonary rehabilitation, and gas exchange relevant to CPET.
The 28th edition of the European CPET Practicum — a 3-day enhanced iPOETTS format covering perioperative CPET interpretation and comorbidities including heart failure, pulmonary hypertension, respiratory disease, and paediatric CPET, combined with small-group interpretation tutorials and an abstract competition. Rooted in the Wasserman/Whipp tradition; one of the most hands-on CPET-focused courses in Europe and directly relevant for practitioners working across adult and paediatric cardiopulmonary populations.
For: preventive/sports cardiologists, exercise physiologists, rehab teams
The most CPET-relevant ESC sub-specialty congress, run by the European Association of Preventive Cardiology. Core themes include cardiac rehabilitation, sports cardiology, and exercise physiology — closely aligned with clinical exercise testing.
ECSS 2027 — European College of Sport Science Annual Congress
📍 Manchester Central, Manchester, UK🕒 Jul 20–23, 2027
For: sport scientists, exercise physiologists, researchers, students
One of the world's leading sport-science congresses, spanning physiology, biomechanics, and performance science. The 32nd edition is hosted by Manchester Metropolitan University’s Institute of Sport under the theme “Redefining boundaries — sport science in the city of champions,” with roughly 3,000 delegates expected.
ESC Congress 2027 — European Society of Cardiology
📍 Milan, Italy🕒 Aug 27–30, 2027
For: cardiologists, researchers, allied health professionals
The world’s largest cardiology congress moves to Milan for 2027. Programming spans the full breadth of cardiovascular medicine, including the preventive and sports cardiology streams most relevant to exercise testing, cardiac rehabilitation, and functional capacity assessment.
For: pulmonologists, respiratory scientists, allied health
The world’s largest respiratory meeting returns to Italy. Announced priority topics include prevention across the lifespan, early detection, and lifestyle change as an actionable strategy — alongside the standing programming on exercise limitation, gas exchange, and pulmonary rehabilitation that makes ERS valuable for CPET practice. Note: ERS pages currently list both Sep 11–14 and Sep 11–15; verify before booking.
The next edition of the European CPET Practicum, organised by CPX International in the Wasserman/Whipp tradition. Confirmed for Munich in October 2027 (organisers note it will not clash with Oktoberfest); exact dates and the venue are still to be announced. Expect the usual mix of didactic lectures, small-group interpretation tutorials, and hands-on laboratory sessions.
Always confirm dates, formats, and registration on the official society pages before making travel plans — locations and dates for future editions are subject to change. Suggest an event to add via the newsletter contact.
Unsubscribe
Newsletter preferences
Enter the email address you subscribed with. We’ll send you a confirmation link — one click and you’re removed.
The confirmation step keeps anyone else from unsubscribing you. Prefer not to wait? Reply to any newsletter email and you’ll be removed manually.
CPET · May 3, 2026
How to Think During a CPET
By Mandeepa · 7 min read
Most people focus on what the numbers mean in Cardiopulmonary Exercise Testing (CPET). But the real skill lies in how you think while the test is happening.
Here is a practical 7-step mindset framework to help you think like a true exercise physiologist.
🔹 1. Start with a Hypothesis, Not Assumptions
Before the test begins, ask yourself: What am I expecting — cardiac limitation? Pulmonary? Deconditioning? Autonomic? Your brain should be forming questions, not conclusions. A thorough medical history and physical activity questionnaire helps tremendously in shaping these early hypotheses.
🔹 2. Think in Systems, Not Variables
VO₂, VCO₂, HR, VE — these are not isolated numbers. They are a conversation between systems:
Heart ❤️ — cardiac output and stroke volume
Lungs 🫁 — ventilatory efficiency and gas exchange
Muscles 💪 — oxygen extraction and peripheral demand
Nervous System ⚡ — autonomic regulation and chronotropic response
Learn the 9-panel Wasserman plot. Always ask: "Do these responses make sense together?"
🔹 3. Track the Story, Not Just Peak Values
CPET is not a snapshot — it's a movie 🎬. Watch how physiology evolves from rest → unloaded → anaerobic threshold → peak. Is there a smooth progression or an early disruption? The pattern tells you far more than the endpoint alone. This is why understanding VO₂ kinetics and heart rate kinetics is so important.
🔹 4. Identify the First Abnormal Signal
The earliest deviation is often the most valuable clue. Ask: What breaks first?
The first failure ≠ the loudest failure. The earliest signal often holds the most diagnostic weight.
🔹 5. Always Challenge Your Own Interpretation
Good physiologists don't just interpret — they doubt intelligently. Ask yourself: "What else could explain this?" and "Am I missing a simpler explanation?" This prevents overdiagnosis and builds real clinical sharpness over time.
🔹 6. Connect Physiology to the Patient in Front of You
Numbers don't experience symptoms — patients do. Always connect the data to the person: dyspnea, fatigue, perceived effort. Does the physiology explain their complaint? If not, why not?
🔹 7. End with a Mechanism, Not Just a Report
Anyone can describe data. Few can explain why it happened. Your goal is to move from:
Data → Pattern → Mechanism → Clinical Meaning
CPET is not just a test. It's real-time physiology unfolding in front of you. Train your mind to see connections, sequences, and mechanisms — and you'll think like a true exercise physiologist.
A patient hands you their phone. Resting heart rate 58. HRV 43 ms. SpO₂ 97%. Respiratory rate 14.2. Readiness 64.
Five numbers, one screen, identical formatting. Same font, same card, same two significant figures, no error bars. Nothing on that screen tells you that the first was counted, the third was estimated, and the last was predicted by a proprietary model you will never see.
All five came from the same source: a small optical ripple at the skin surface. Understanding how that ripple becomes a dashboard is the difference between using wearable data well and being quietly misled by it.
🔹 The principle: light in, light out
Photoplethysmography (PPG) is an optical measurement of blood volume change. It is the same physics as the pulse oximeter you clip on a finger in the lab — only reflected back rather than transmitted through.
An LED shines light into the skin.
Hemoglobin absorbs it. Every systolic surge pushes blood into the tissue bed beneath the sensor, so absorption rises.
A photodiode measures the light that returns — less during systole, more during diastole.
Those rhythmic dips, plotted over time, are the PPG waveform.
Note what is not happening. No electrical activity is recorded. The device detects a mechanical consequence of the heartbeat, one arterial transit downstream of the event itself.
🔹 Everything comes from one percent
The PPG waveform has two components, and the ratio between them explains almost every limitation that follows.
The DC component is a large, static baseline — skin, bone, fat, muscle, venous blood. It carries no cardiac information. The AC component is a small pulsatile ripple riding on that baseline, and it is the arterial pulse. That ripple, as a percentage of the baseline, is the perfusion index.
Perfusion index by wear site
Finger — 2 to 5%
Wrist — 0.5 to 2%
Every metric a consumer wearable reports is extracted from this fraction of the optical signal. The rest is noise it has to see through.
The optical path, the wear sites, and the measurement-to-prediction ladder.
🔹 Why the site changes everything
Three variables determine what a sensor can see: how well the tissue is perfused, how deep the vessels sit, and how much the sensor moves relative to the skin. Wear site governs all three — which is why form factor predicts performance better than brand does.
Ring — finger, digital arteries
Dense capillary beds, superficial digital arteries, short optical path. The highest signal-to-noise ratio of any consumer site, and the traditional clinical location for pulse oximetry. The cost is vasoconstriction: cold hands or sympathetic drive collapse finger perfusion. The same vasomotor responsiveness that makes the site good makes it unstable.
Watch — wrist, radial artery
The radial artery sits beneath fascia and muscle, limiting optical access. Add tendon movement, wrist flexion, sweat, and variable strap tension. Manufacturers compensate with multi-LED arrays and accelerometer-based motion cancellation — algorithmic corrections, not a better signal.
Earbud — ear, auricular vessels
Rich perfusion from the superficial temporal and posterior auricular arteries, thin tissue, and minimal motion at the sensing site. Your head moves far less than your wrist during a run. The limitation is commercial rather than physiological: several validated ear-PPG products have shipped and been discontinued.
Chest strap — thorax, electrical
Not PPG at all. An ECG electrode records the electrical event directly, giving a sharp, unambiguous R-peak that can be timestamped to the millisecond. It is the reference every optical device is validated against, and still the correct choice when beat timing is the measurement.
One underappreciated consequence: wrist signal quality is highest supine, degrades sitting, degrades further standing, and is best when the sensor sits at heart height. Hydrostatics show up in your morning readings.
🔹 Why wavelength matters
Short wavelengths scatter and are absorbed quickly. Long wavelengths travel further through tissue — the reason red light glows through your palm against a flashlight and green light does not.
Green (≈530 nm). Hemoglobin absorbs green strongly, producing high contrast between pulse and no-pulse, and therefore a crisp waveform. Staying shallow also means deeper tissue sliding during movement corrupts it less. Ideal for heart rate — and it tells you nothing about what is in the blood.
Red (≈660 nm) and infrared (≈940 nm). Oxygenated and deoxygenated hemoglobin absorb these two wavelengths in different ratios. Deeper penetration reaches arterial blood, but the signal is more motion-sensitive, which is why saturation readings are usually taken at rest or during sleep.
Here is the part usually left out. One wavelength alone is uninterpretable. If the red signal returns weak, that could be desaturation — or thick tissue, a loose band, skin pigmentation, or a cold finger. There is no way to tell.
The second wavelength is a control. Everything that is not oxygen — tissue thickness, pigmentation, sensor fit, perfusion — affects both wavelengths in roughly the same direction. Take the ratio, and those confounders largely cancel. What survives the division is saturation.
The second colour is not extra information. It is the reference that makes the first colour mean anything.
🔹 One waveform, many metrics — not equally
Every number below is derived from the same optical ripple. They are not equivalent claims. Each step adds a layer of inference, and the interface shows you none of it.
1 · A MEASUREMENT
Heart rate
Time between consecutive systolic peaks. Count the peaks, invert the interval.
2 · INDIRECT, STILL A MEASUREMENT
SpO₂
Ratio of pulsatile absorption at two wavelengths, calibrated against arterial blood gas data. Indirect, but anchored to real physics.
3 · AN INFERENCE
Heart rate variability
Technically pulse rate variability. Each interval includes the pre-ejection period and pulse transit time, and neither is constant — both shift with blood pressure, vascular tone, and sympathetic drive. That added variance is real, but it is vascular, not cardiac.
4 · A DERIVED SIGNAL
Respiratory rate
Extracted from three ways breathing modulates the waveform: baseline drift from intrathoracic pressure, amplitude modulation, and respiratory sinus arrhythmia. A signal that was never the sensor's target.
5 · A PREDICTION
Readiness · Stress · Vascular age · VO₂max
Model outputs. Optical data combined with accelerometry, temperature, sleep timing, and demographics, passed through a proprietary regression that has usually never been published or independently validated.
🔹 Same device, different answer
Because the usable signal is so small, conditions that seem irrelevant move the numbers substantially. The same watch on the same person will report differently depending on perfusion, motion, skin temperature, strap tension, skin tone, posture, sensor height relative to the heart, and ambient light.
This is the practical case for reading wearable data as a within-person trend rather than a population comparison. A single value against a normative table is weak. The same person, same conditions, measured repeatedly — before and after a training block, before and after a cardiotoxic exposure, at baseline and follow-up — is where these devices genuinely earn their place.
🔹 What to do with the dashboard
None of this is an argument against wearables. Continuous, longitudinal, real-world physiological data at population scale is something we have never had before, and it is genuinely valuable.
It is an argument against treating every number on the screen as the same kind of claim.
When a patient shows you their data, the useful questions are: which rung is this number on, what conditions was it collected under, and am I looking at a value or a trend? Heart rate from a resting overnight window is worth taking seriously. A readiness score is a vendor's opinion rendered as an integer.
Bottom line
Your watch measures light. Everything else is inference — and the further down the ladder a number sits, the less it is a measurement and the more it is a prediction wearing a measurement's clothing.
The user cannot see where any given number falls on that ladder. Clinicians can, and should.
We open every exercise physiology lecture with the same equation:
VO2 = HR × SV × (CaO2 − CvO2)
And then we spend the next fifty minutes on the left ventricle.
It is an understandable bias. The heart is the organ we image, the organ we medicate, the organ that fails in ways that end lives. But the Fick equation has an upstream and a downstream, and the ventricle sits in the middle of a circulatory loop that includes two other muscle systems with just as much claim to setting the ceiling.
One of them delivers blood to the heart. The other actively competes with the legs for it.
Miss either, and you will misread the tracing in front of you.
🔸 Skeletal muscle — the pump we forget
The heart can only eject what comes back to it. That much is uncontroversial. What is less appreciated is how thin the margin is.
Venous return is pressure-driven flow, and Guyton's formulation makes the drivers explicit:
VR = (MSFP − RAP) / RVR
Mean systemic filling pressure — the pressure the circulation would equilibrate to if the heart stopped — sits at roughly 7 mmHg at rest. Right atrial pressure is near zero. So the entire driving gradient returning blood to the heart is about seven millimetres of mercury.
Not arterial pressure. Not 120 over 80. Seven.
Most of your blood isn't doing anything
Around 70% of total blood volume sits in the venous system, but the majority of it is unstressed volume — it fills the vessel to its resting dimensions without distending the wall, and therefore contributes nothing to MSFP. Only the stressed volume, roughly a quarter of the total, actually generates pressure.
Most of the blood in your veins is generating no pressure at all.
MSFP is simply stressed volume divided by total vascular compliance. And because venous compliance is on the order of twenty times arterial compliance, the veins set that number almost single-handedly. The splanchnic bed alone holds 20–25% of blood volume, sitting there as a reservoir.
Every mechanism that raises venous return during exercise is doing the same job: converting unstressed volume into stressed volume, or lowering the resistance to its return.
The four pumps
The skeletal muscle pump dominates during upright dynamic exercise. Contraction compresses intramuscular veins and ejects blood centrally; one-way valves prevent backflow. The half that gets less attention is relaxation — intramuscular venous pressure falls sharply, creating a suction gradient that also augments arterial inflow. Ankle venous pressure drops from around 90 mmHg standing still to roughly 25 mmHg during walking.
Note the requirement: rhythmic, dynamic contraction. Sustained isometric work loses the pump entirely, which is a large part of why static exercise produces such a different hemodynamic profile.
The respiratory pump pushes and pulls simultaneously. Inspiration lowers intrathoracic pressure — from around −5 mmHg at rest to −20 or −30 mmHg during heavy exercise — which drops RAP and widens the gradient. At the same time, diaphragmatic descent raises intra-abdominal pressure and squeezes the hepatic and splanchnic veins.
This is why a Valsalva manoeuvre collapses venous return, and why Fontan patients live and die by their breathing pattern.
Sympathetic venoconstriction raises MSFP directly. Alpha-adrenergic constriction of splanchnic and cutaneous veins mobilises 500–800 mL of otherwise inert reserve, taking MSFP from ~7 to 15–20 mmHg. Worth noting the competition here: cutaneous veins constrict early in exercise, then dilate for thermoregulation — one contributor to cardiovascular drift in a warm lab.
Diastolic suction is the fourth, and the one most often omitted. At high contractility, end-systolic volume falls below the ventricle's equilibrium volume; elastic recoil then generates a transiently negative pressure that actively draws blood in. This is what keeps RAP low despite a four- to five-fold rise in flow.
The punchline: two curves, one operating point
Plot the venous return curve — descending, because as RAP rises the gradient narrows and flow falls — against the cardiac function curve, which ascends because more filling pressure means more stretch and more stroke volume. Where they cross is where the circulation actually operates. Both constraints must be satisfied at once.
Both curves must be satisfied at once. Shift only the cardiac curve and flow barely moves.
Now do the thought experiment that makes the point:
Give a heart maximal inotropic and chronotropic drive but leave the venous return curve exactly where it was. Cardiac output barely moves. You simply slide up along a fixed curve toward its plateau — a plateau set by venous collapse at the thoracic inlet once transmural pressure reaches zero.
Cardiac output cannot increase unless the venous return curve shifts. The pump cannot outrun its filling.
The experimental record backs this up cleanly. Lower body negative pressure reduces VO2max acutely. Plasma volume expansion raises it. Bed rest drops plasma volume and VO2max together, and re-expansion restores much of the loss. Blood volume expansion is among the earliest measurable training adaptations, and it tracks VO2max about as well as any single variable we have.
🔸 The diaphragm — a competitor, not a bystander
The oxygen cost of breathing scales roughly with the square of flow, because the work of breathing does. At rest, respiratory muscles consume 1–2% of whole-body VO2. At maximal exercise, that rises to 10–15% of VO2max, and higher still in endurance athletes ventilating 180+ L/min.
That oxygen is going to the diaphragm, intercostals, scalenes and abdominals — not to the legs.
The metaboreflex
This is where it stops being a simple accounting problem.
Harms and colleagues, working in Dempsey's laboratory, ran the definitive experiment in 1997. Seven trained cyclists exercised at VO2max while inspiratory muscle work was either reduced with a proportional-assist ventilator, increased with graded resistive loads, or left alone.
The findings were unambiguous. Up to 14–16% of cardiac output was directed to the respiratory muscles at maximum. Leg VO2 as a fraction of total VO2max was 81% under control conditions — it rose to 89% with respiratory unloading and fell to 71% with loading.
Unload the respiratory muscles and leg flow rises. Load them and it falls.
The follow-up performance study made the consequence concrete: time to exhaustion at 90% VO2max increased by about 14% with respiratory unloading and fell by about 15% with loading.
Breathing doesn't just consume oxygen. It actively redistributes it away from the muscles doing the work.
When the lungs actually become limiting
In healthy untrained people, they usually don't. Breathing reserve stays preserved — peak VE typically reaches only 60–75% of MVV — arterial saturation holds, and the respiratory system is comfortably overbuilt relative to the cardiovascular one. That is precisely why a low peak VO2 with intact breathing reserve should push you toward the circulation.
It becomes limiting in four settings:
Elite endurance athletes, where exercise-induced arterial hypoxemia affects roughly half of the cohort — ventilation-perfusion mismatch plus diffusion limitation from very short pulmonary capillary transit times at cardiac outputs above 30 L/min. Falling CaO2 reduces VO2max directly, and supplemental oxygen restores it.
Expiratory flow limitation, where tidal breathing meets the maximal flow-volume envelope and ventilation can only rise by increasing end-expiratory lung volume. Dynamic hyperinflation raises elastic work — and the higher intrathoracic pressures impede venous return, looping us straight back to the first section.
Obstructive and restrictive disease, where reserve is consumed early and VE/VCO2 climbs.
Aging, where chest wall compliance falls and the margin narrows.
One practical note: inspiratory muscle training reliably improves endurance performance but rarely raises VO2max in healthy people. It works by delaying the metaboreflex, not by adding delivery capacity.
🔸 The myocardium — relaxation over contraction
Contractility gets the attention, and it is what HFrEF destroys. But it is one of four properties.
Chronotropy — heart rate reserve. Chronotropic incompetence caps cardiac output directly and appears on CPET as a low peak HR with a shallow HR/VO2 slope: the mirror image of the preload-failure pattern.
Lusitropy — the rate of relaxation, and the property most directly threatened at peak exercise. Consider the arithmetic.
The filling window collapses roughly fourfold exactly when stroke volume must be highest.
At HR 60, the cardiac cycle is 1000 ms with roughly 600 ms of diastole. At HR 190, the cycle is 316 ms with roughly 130 ms of diastole. Systole shortens far less than diastole does. The filling window compresses four- to five-fold at precisely the moment the required stroke volume is highest.
That only works if beta-adrenergic phosphorylation of phospholamban accelerates SERCA2a calcium reuptake enough to get the ventricle relaxed in time. When it doesn't, filling truncates. This is much of what limits HFpEF patients.
Diastolic suction, as above — contractility and filling are coupled, not independent.
Structural adaptation, and its limits
Endurance training produces eccentric hypertrophy: chamber enlargement with proportional wall thickening, larger end-diastolic volume, improved compliance. LV end-diastolic volume correlates with VO2max about as well as any single cardiac measure, and detraining reverses it.
The pericardium is a genuine constraint at the top end — in animal models, opening the pericardium increases peak stroke volume. The highly trained heart can be limited by the sac it sits in.
The right ventricle deserves separate billing
Pulmonary artery pressures rise progressively with exercise intensity, so the harder someone works, the greater the RV afterload. La Gerche's group has shown that end-systolic wall stress increases disproportionately in the RV compared with the LV during exercise — an observation that has reframed the RV as, in their phrase, a potential Achilles' heel.
Through ventricular interdependence, RV dilation shifts the septum and impairs LV filling. In Fontan physiology, pulmonary hypertension, and anomalous pulmonary venous return, the right side is where peak VO2 is actually lost.
The coronary constraint
Left ventricular coronary perfusion happens almost entirely during diastole. The same compression of diastole that limits filling also limits myocardial perfusion — exactly when myocardial oxygen demand peaks. In significant coronary disease this produces ischemic contractile dysfunction at peak, visible as an O2 pulse that plateaus or falls outright, sometimes accompanied by a drop in systolic pressure.
🔸 What this means at the console
Here is the honest limitation of non-invasive testing:
An early O2 pulse plateau with preserved breathing reserve tells you stroke volume has hit a ceiling. It does not tell you why.
Preload insufficiency, impaired lusitropy, excess afterload, and pericardial constraint all flatten that curve identically.
A flat O2 pulse tells you stroke volume is capped. It does not tell you why.
What you have to work with:
BP trajectory — flat or falling systolic pressure suggests outflow or forward failure. An exaggerated hypertensive response suggests stiffness and filling constraint.
HR/VO2 slope — a steep spike is chronotropic compensation for volume the ventricle isn't receiving.
Delta VO2/delta WR — flattening below ~8–10 mL/min/W, especially a late inflection, indicates delivery failure.
PETCO2 and VE/VCO2 — track them through the plateau, not just at peak. Abrupt versus gradual change distinguishes shunt from pulmonary vascular disease.
Breathing reserve — intact reserve moves the diagnosis to the circulatory side of the ledger.
SpO2 — a step change suggests right-to-left shunt; a gradual drift suggests diffusion limitation.
And then there is the ceiling on all of it. Oldham and colleagues, reviewing 619 consecutive clinically indicated invasive CPETs, established that inadequate ventricular filling from low venous pressure is a real and clinically relevant cause of exercise intolerance — proposing thresholds of peak RAP below 6.5 mmHg and peak PCWP below 12.5 mmHg for preload insufficiency. In a subset who underwent repeat testing after saline loading, most responded with meaningful increases in cardiac output, stroke volume and peak VO2.
That is the diagnosis non-invasive CPET cannot make. It is also the diagnosis that the first section of this article predicts should exist.
🔸 The takeaway
VO2max is a whole-loop property.
The skeletal muscle pump determines what arrives at the heart. The diaphragm decides how much of the output the legs are allowed to keep. The myocardium — through relaxation as much as contraction, and through the right ventricle as much as the left — determines what can be moved in the time available.
Next time you read a tracing, don't stop at the heart.
🔸 References
Guyton AC. Determination of cardiac output by equating venous return curves with cardiac response curves. Physiol Rev. 1955;35(1):123–129.
Harms CA, Babcock MA, McClaran SR, et al. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol. 1997;82(5):1573–1583.
Harms CA, Wetter TJ, McClaran SR, et al. Effects of respiratory muscle work on cardiac output and its distribution during maximal exercise. J Appl Physiol. 1998;85(2):609–618.
Harms CA, Wetter TJ, St Croix CM, Pegelow DF, Dempsey JA. Effects of respiratory muscle work on exercise performance. J Appl Physiol. 2000;89(1):131–138.
Wetter TJ, Harms CA, Nelson WB, Pegelow DF, Dempsey JA. Influence of respiratory muscle work on VO2 and leg blood flow during submaximal exercise. J Appl Physiol. 1999;87(2):643–651.
Dempsey JA, Romer L, Rodman J, Miller J, Smith C. Consequences of exercise-induced respiratory muscle work. Respir Physiol Neurobiol. 2006;151(2–3):242–250.
Aaron EA, Seow KC, Johnson BD, Dempsey JA. Oxygen cost of exercise hyperpnea: implications for performance. J Appl Physiol. 1992;72(5):1818–1825.
Oldham WM, Lewis GD, Opotowsky AR, Waxman AB, Systrom DM. Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing. Pulm Circ. 2016;6(1):55–62.
Joseph P, Arevalo C, Oliveira RKF, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160(2):642–651.
La Gerche A, Heidbüchel H, Burns AT, et al. Disproportionate exercise load and remodeling of the athlete's right ventricle. Med Sci Sports Exerc. 2011;43(6):974–981.
La Gerche A, Rakhit DJ, Claessen G. Exercise and the right ventricle: a potential Achilles' heel. Cardiovasc Res. 2017;113(12):1499–1508.
Willeput R, Rondeux C, De Troyer A. Breathing affects venous return from legs in humans. J Appl Physiol. 1984;57(4):971–976.
Bassett DR Jr, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000;32(1):70–84.
Convertino VA. Blood volume: its adaptation to endurance training. Med Sci Sports Exerc. 1991;23(12):1338–1348.
WEARABLES · August 7, 2026
48 on Your Watch, 41 on the Cart
By Mandeepa · 11 min read
A patient sits down after their cardiopulmonary exercise test. They pull up their wrist.
"My watch says my VO2max is 48. Your test said 41. Which one is right?"
It is a fair question, and the honest answer is more interesting than "the lab is right." Their watch did not measure something wrong. It measured something entirely different from what we measured — and understanding what, exactly, turns an awkward moment into one of the better teaching opportunities in clinical exercise physiology.
🔸 The first thing to say out loud
No smartwatch measures oxygen.
There is no gas analyzer on a wrist. No mixing chamber, no flow sensor, no CO2 line. Every VO2max figure on every consumer device is a prediction generated from proxies — and the proxies differ enough between brands that two watches on the same wrist can disagree by 10 mL/kg/min.
The devices split into two algorithmic families. Which family a device belongs to matters more than which company made it.
🔸 Family 2: the devices that never watch you exercise
Start with this one, because it is the simpler case.
Polar's Fitness Test is the clearest example. You lie down. You stay still for five minutes. The device reads your resting heart rate and your resting heart rate variability, then pulls in your age, sex, height, body mass, and self-reported training background. From those inputs it produces the Polar OwnIndex, which Polar describes as comparable to VO2max.
Fitbit works similarly when GPS running data is not available — the company states the Cardio Fitness Score is determined by resting heart rate, age, sex, weight, and other personal information, with the specific algorithm proprietary. Whoop uses a related approach, drawing on resting heart rate, HRV, and activity metrics without requiring a specific outdoor session.
The physiology underneath is real but blunt: fitter people tend to have lower resting heart rates and higher resting HRV. The algorithm works backward from that association to ask what VO2max people with these resting characteristics typically have.
Note the word typically. There is no workload anywhere in this calculation. No oxygen. No exercise at all.
🔸 Family 1: the devices that watch you run
This is the family worth understanding in detail, because it is where the better algorithms live and where the interesting failure modes are.
Garmin, Apple, Coros, Suunto, and Polar's running mode all belong here. Conceptually it is the Astrand-Ryhming logic every exercise physiologist learns — extrapolating a submaximal heart rate response to a predicted maximum — with GPS pace substituted for a calibrated ergometer load.
Step 1 — collect paired observations. During an outdoor run the device logs heart rate, from wrist PPG or a paired chest strap, alongside speed from GPS or a footpod. Every few seconds it has a paired data point: at 6:00/km your heart rate is 140; at 5:00/km it is 160.
Step 2 — filter out the untrustworthy data. This is where algorithms separate from each other, and Garmin's is the only one whose method is publicly documented. Firstbeat segments the run by heart rate range, then within each segment computes the correlation between heart rate and speed and compares it against the variance in that segment. Low correlation combined with wide variance means the segment is not telling you anything reliable, so it is discarded. The published white paper names the specific triggers: soft ground, steep downhill sections, stopping at traffic lights where speed drops to zero while heart rate stays elevated, and cardiovascular drift during long workouts.
Step 3 — fit a line and extrapolate. The surviving segments define a heart rate-speed relationship. Extend that line to the assumed maximum heart rate and you get a theoretical maximum sustainable speed. Firstbeat takes a reliability-weighted average across segments rather than one regression through all points, which means a clean 400 m stretch counts for more than a noisy kilometre.
Step 4 — convert speed to an oxygen cost. That theoretical maximum speed is converted using the established linear relationship between running speed and VO2 — the same physiology behind the ACSM running equation. That output is the number on the screen.
🔸 The assumption chain
Stated plainly, Family 1 assumes the heart rate-VO2 relationship is linear across the submaximal range; that running speed is a valid proxy for external work; that your running economy is close to the population average; and that your maximum heart rate is what the device assumed it was.
Every one of those is defensible in a healthy recreational runner. Every one is questionable in the populations we test.
🔸 How the brands differ within Family 1
They are not interchangeable. Five real distinctions:
What counts as workload. Garmin, Apple, Coros, and Suunto use GPS pace. Polar's cycling test uses functional threshold power instead — the maximum power sustainable for 60 minutes — which removes the running-economy assumption entirely by measuring external work directly. That is a genuinely better input, limited only by requiring a power meter.
Whether a protocol is imposed. Apple and Garmin harvest free-living runs passively. This has real ecological validity, but the algorithm has no control over surface, grade, wind, or fatigue state. Polar's walking test imposes a protocol. It is a trade-off between clean input and user compliance, and neither answer is obviously right.
Data qualification thresholds. Apple requires outdoor walking, running, or hiking on ground under 5% grade, with adequate GPS and heart rate signal and roughly a 30% rise in heart rate above resting, across multiple sessions before it will produce an estimate. Firstbeat's filtering happens at the segment level rather than the session level. Coros simply accumulates outdoor runs and adjusts over time.
Heart rate source. All of these accept a chest strap; all default to wrist PPG. The INTERLIVE meta-analysis found that devices using photoplethysmography showed greater bias and wider limits of agreement than those using a chest strap. For a user who cares about the number, pairing a strap is the single highest-value change available.
How maximum heart rate is handled. Nearly all default to 220 minus age. Garmin will update it from observed data and lets you enter a measured value. Apple does not expose it at all. Given the sensitivity shown above, this is not a minor interface difference.
Now consider who the HRmax assumption fails hardest. Beta blockade. Chronotropic incompetence. Post-anthracycline cardiotoxicity. Atrial fibrillation. Pediatric populations, where 220 minus age was never validated in the first place. These are precisely the patients for whom aerobic capacity carries the most clinical weight.
🔸 What the validation literature shows
The INTERLIVE consortium's meta-analysis of 14 validation studies is the best available head-to-head between the two families.
Algorithm type
Bias
95% limits of agreement
Exercise-based (Family 1)
-0.09 mL/kg/min
-9.92 to +9.74
Resting-based (Family 2)
+2.17 mL/kg/min
-13.07 to +17.41
Family 1 wins clearly. But read the limits of agreement, not the bias. A pooled bias of -0.09 mL/kg/min looks superb. It is not. It is an artifact of averaging — positive and negative errors of substantial magnitude cancelling each other out. For any individual, that spread of roughly 10 mL/kg/min in either direction is an entire FRIEND fitness category.
Device
Study
Result
Garmin fenix 6
Sensors 2025;25:275 (n=19, ParvoMedics)
MAPE 7.05%, Lin's CCC 0.73
Garmin Forerunner 920XT
Passler et al., IJERPH 2019;16:3037 (n=24)
MAPE 7.3%, significant underestimation
Garmin Forerunner 245
Engel et al., Eur J Appl Physiol 2025
Underestimated by 4.7 and 4.1 mL/kg/min; MAPE 7.9% and 7.2%
Apple Watch S9 / Ultra 2
Lambe et al., PLOS ONE 2025 (n=28, COSMED)
Underestimated by 6.07; LoA -6.11 to +18.26; MAPE 13.31%
Apple Watch S7
Caserman et al., JMIR Biomed Eng 2024
Underestimated by approximately 4.5
Coros, Suunto, Samsung
—
No independent peer-reviewed VO2max validation identified as of August 2026
🔸 Why Garmin comes out ahead
Three things, and only the third is about the numbers.
The method is published. Firstbeat documented how the algorithm works, including its own sensitivity analysis on HRmax error. Apple's is proprietary — the researchers validating it noted explicitly that they cannot know which features drive the prediction. You can reason about the failure modes of a documented algorithm. You cannot reason about a black box.
The results replicate. Three independent research groups, three different Garmin models spanning roughly six years of hardware, three different laboratories and metabolic carts — landing within one percentage point of each other. One favourable study can be a lucky sample. Three that agree is a property of the algorithm.
The error is roughly half. Approximately 7% MAPE versus 13.3%.
One caveat, because the comparison is not perfectly clean: the Apple and Garmin studies used different criterion protocols, and the Apple sample skewed heavily toward Excellent and Superior FRIEND categories — exactly the range where these algorithms underestimate. Some of that 13.3% is sample composition rather than algorithm quality. The defensible claim is that Garmin has more evidence, more consistent evidence, and a transparent method. Not that its algorithm is objectively twice as good.
🔸 The failure mode that matters most
Engel and colleagues stratified their Forerunner 245 results by training status.
Subgroup
MAPE
ICC
Moderately trained
2.8-4.1%
0.63-0.66
Highly trained
9.4-10.4%
0.34-0.41
In the highly trained group the watch underestimated VO2max by 6.3 mL/kg/min and reliability collapsed. Caserman found the mirror image in Apple Watch users: overestimation in individuals with poor fitness, underestimation in those with excellent fitness.
This is regression toward the population mean, and it has a direct consequence: validity is not a property of the device. It is a property of where the individual sits relative to the algorithm's training data.
A device with 4% error in recreational runners can be close to useless at either tail. Which is the reason none of this transfers to clinical populations without fresh validation. Our patients are not at a tail of the training distribution. They are off the distribution entirely — different heart rate responses, different mechanical efficiency, different relationships between effort and pace. The algorithm has never seen them.
🔸 Putting the error in context
Laboratory indirect calorimetry is not error-free either. Measurement error for CPET is approximately 5%, with a pooled mean standard error near 2.6 mL/kg/min. Traditional submaximal prediction equations carry a standard error of estimate around 3.7 to 4.5 mL/kg/min.
So the honest framing is this: a good wearable is not competing with CPET. It is competing with a submaximal step test — and in the tails, it loses to one.
🔸 How to talk to a patient who brings you their watch
Do not dismiss the number. Someone who tracks their own physiology is doing something we generally spend a lot of effort trying to persuade people to do. Dismissing the number dismisses the behaviour, and the behaviour is worth protecting.
Explain what it measured. Plain language works: "Your watch measured your pace and your pulse. It never measured oxygen. It used a population equation to make an educated guess from those two things." Most people have simply never been told this, and most find it genuinely interesting rather than deflating.
Reframe where the value sits. The absolute number is unreliable for any individual. The trend is not — same device, same conditions, tracked over months. Tell them to watch the direction, not the digit. That reframe preserves the motivational value while correcting the epistemic error.
If they want a better number, two concrete actions: pair a chest strap, and enter a measured maximum heart rate if the device allows it. Both address documented error sources.
Explain what the test added. This is the real teaching moment, and the one we tend to skip. Their watch produced one extrapolated endpoint. The test they just completed produced VE/VCO2 slope. Ventilatory thresholds. O2 pulse. Breathing reserve. Oxygen uptake efficiency slope. Heart rate recovery. The shape of the response, not just its ceiling.
Bottom line
The watch answers how much. CPET answers why — and "why" is the question that brought them to us in the first place.
Key references: Molina-Garcia P et al. Validity of estimating the maximal oxygen consumption by consumer wearables: systematic review with meta-analysis and expert statement of the INTERLIVE Network. Sports Med. 2022;52(7):1577-97. · Engel F et al. Eur J Appl Physiol. 2025. doi:10.1007/s00421-025-05923-x · Lambe R et al. Investigating the accuracy of Apple Watch VO2 max measurements. PLOS ONE. 2025;20(5):e0323741. · Caserman P et al. JMIR Biomed Eng. 2024;9:e59459. · Passler S et al. Int J Environ Res Public Health. 2019;16(17):3037. · Sensors. 2025;25(1):275. · Firstbeat Technologies. Automated fitness level (VO2max) estimation with heart rate and speed data. White paper, 2014, rev. 2017. · Parak J et al. JMIR Mhealth Uhealth. 2017;5(7):e97.
VO2peak vs VO2max: The One-Letter Difference Your Report Can't Fudge
By Mandeepa · 6 min read
Two numbers. Same units. Same machine. Sometimes even the same test. But if your report says "VO2max" when what you actually captured was a VO2peak, you've made a claim your data can't back up.
Every VO2max is a VO2peak. Not every VO2peak is a VO2max.
🔹 The core definition
VO2max is a true maximal aerobic capacity — the point where oxygen uptake stops rising no matter how much harder the workload gets. This is confirmed, not assumed — classically it requires an objective plateau in VO2 despite an increasing work rate.
VO2peak is the highest VO2 value actually recorded during a specific test, without that plateau confirmation. The test ended because of symptoms, fatigue, or protocol limits — not because you can prove the person hit their physiological ceiling.
Every VO2max is technically a VO2peak. Not every VO2peak is a VO2max.
🔹 Where to find it on the printout
You're looking in the same place for both — the terminology depends on what the data shows, not which button you pressed.
Where to look
What confirms a plateau
VO2 vs. work rate trace (Panel 3)
A visible flattening in the last 15–30 seconds before termination
Breath-by-breath VO2 column
The last four to six 30-second averages show minimal delta between them
Summary "peak" value box
Nothing — the software prints whatever it captured as peak regardless of plateau. It doesn't make the max-vs-peak call for you.
🔹 5 variables that separate peak from max
When a plateau isn't clearly visible — which, on a ramp protocol, is most of the time — these are the secondary criteria labs lean on.
Variable
Threshold
Reliability
1. Plateau
ΔVO2 < 150 mL/min
The classic 1955 Taylor criterion — notoriously inconsistent across protocols and averaging methods
2. RER
≥ 1.10–1.15
Evidence of near-maximal anaerobic contribution — easier to hit than a plateau, part of the controversy
3. Heart rate
Within ~10 bpm of HRmax
Weak in isolation; age-predicted formulas carry wide error bands, especially with altered chronotropy
4. Blood lactate
≥ 8 mmol/L
Strong supporting evidence, rarely captured outside research or performance labs — needs capillary sampling
5. RPE
Borg 17–19
The softest criterion — reflects motivation and symptom tolerance as much as physiology; often the real reason the test stopped
Most ramp-protocol CPETs meet two or three of these without ever showing a clean plateau. Call it what it is — that test result is a VO2peak.
🔹 What VO2 kinetics actually looks like
Kinetics is a different question from "what's the peak number" — it's the shape of the response over time.
Below threshold, VO2 settles into steady state. Above it, a slow component can drift VO2 all the way to max — kinetics itself becomes the limiting event.
Below threshold (moderate intensity): Phase I (~15–20s, cardiodynamic) → Phase II (τ ~20–30s, exponential rise matching oxidative demand) → Phase III steady state, typically reached within ~3 minutes.
Above threshold (heavy/severe domain): a VO2 slow component appears — VO2 keeps drifting upward at a fixed work rate instead of stabilizing. In the severe domain, this slow component can drag VO2 all the way up to VO2max even without any further increase in workload — kinetics itself becomes the limiting event.
🔹 Across the lifespan: who actually plateaus?
Plateau likelihood isn't fixed — it shifts with age, training status, and physiological reserve.
Population
Plateau likelihood
Why
Pediatric / adolescent
Lower
Smaller stroke-volume reserve and pacing behavior — VO2peak is the honest terminology, not a compromise
Young, trained adults
Highest
Largest cardiac output reserve and fastest oxidative kinetics — the best shot at a true plateau
Older healthy adults
Reduced
HRmax, stroke volume, and O2 extraction all decline, narrowing the runway before volitional fatigue hits first — kinetics slow too (longer τ)
Masters athletes
Well preserved
Often out-plateau sedentary peers decades younger — training status, not age alone, drives the physiology
VO2max is a claim about physiology — a confirmed ceiling. VO2peak is a claim about a test — the best number produced today. If your lab reports "VO2max" by default regardless of whether a plateau occurred, the number probably isn't wrong. The label is making a promise the data doesn't keep.
Your Body's Hidden Report Card: What Autonomic Regulation Really Looks Like
By Mandeepa · 6 min read
Most people look at CPET and REE results and see performance metrics. But these numbers quietly reflect something much deeper — how well the autonomic nervous system is regulating the body.
The autonomic nervous system works silently in the background, balancing your sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) responses. When it's functioning well, you won't even notice it. When it's not, the signs show up clearly in CPET and resting measurements — if you know what to look for.
Here are the key reference anchors I find incredibly useful in practice:
🫀 Heart Rate Recovery (1 min)
One of the most clinically powerful metrics in CPET. After peak exercise, how quickly does the heart rate drop?
≥ 12 bpm drop → normal parasympathetic reactivation
≥ 20 bpm drop → excellent autonomic recovery
A slow heart rate recovery is one of the earliest and most reliable signs of autonomic dysfunction — and has been linked to increased cardiovascular risk in multiple studies.
🏃 Chronotropic Response
Does the heart rate rise appropriately during exercise? Achieving ~85–100% of age-predicted HRmax suggests appropriate sympathetic activation. Falling short — known as chronotropic incompetence — can indicate blunted autonomic drive, even when peak VO₂ appears normal.
🌬️ VE/VCO₂ Slope
This measures ventilatory efficiency — how hard the lungs are working relative to CO₂ output.
~25–30 → efficient ventilatory control
< 30 → generally optimal in healthy individuals
An elevated slope (>34–36) can indicate pulmonary hypertension, heart failure, or impaired gas exchange — all tied to dysregulated autonomic and cardiovascular control.
🔥 VO₂ Peak
The gold standard of cardiorespiratory fitness. While it varies by age and sex, reaching ≥ 85% of predicted VO₂ peak reflects good integrated cardiovascular and autonomic response. It's not just about the lungs or the heart — it reflects how well every system coordinates under demand.
🌡️ Resting Energy Expenditure (REE)
Often overlooked, REE is a window into metabolic regulation at rest. A value of ~90–110% of predicted suggests balanced metabolic control. Significant deviation in either direction — hypermetabolism or hypometabolism — can signal underlying autonomic or hormonal dysregulation.
⚖️ Respiratory Quotient (RQ)
RQ reflects your body's fuel preference at rest. An RQ of ~0.75–0.85 indicates good metabolic flexibility — the ability to efficiently utilize both fat and carbohydrates. A persistently high RQ at rest (>1.0) may suggest metabolic stress or poor substrate flexibility.
🌿 Resting Heart Rate
In active individuals, a resting HR of ~50–70 bpm reflects strong parasympathetic tone — the autonomic nervous system at ease. Elevated resting HR, particularly above 80–90 bpm, is associated with reduced heart rate variability and heightened cardiovascular risk over time.
🌬️ Resting Ventilation (VE)
A normal resting ventilation of ~5–8 L/min reflects calm, efficient breathing. Elevated resting VE can indicate anxiety, chronic hyperventilation, or early cardiopulmonary compromise — all of which have autonomic underpinnings.
What stands out across all these metrics is not just peak performance — but the smooth coordination between systems. A heart that rises appropriately and recovers quickly. Breathing that matches metabolic demand without excess. Energy expenditure that aligns with predicted physiology.
That's autonomic regulation in action. Not extreme. Not dramatic. Just precise, adaptive, and efficient.
And that's what real physiological fitness looks like.
I Missed Medical School by 2 Marks. Here's Every Path That Opened Instead.
By Mandeepa · 8 min read
At 17, I had it figured out. Science major in high school, medical entrance exam, MBBS, then MD in Cardiology. That was the whole plan, and I didn't have a second one.
The cutoff for a public university seat was 91. I scored 89. Two marks.
I've spent years deciding whether to call that bad luck or good luck, and I've landed firmly on the second. Everything I do now — every cardiopulmonary exercise test I run, every Wasserman 9-panel I interpret — exists because that door closed.
What I want to do here isn't tell a redemption story. It's something more useful: lay out every fork I hit, and every option that was actually sitting on the table at each one. Because when you're 18 and staring at a score that doesn't match your plan, nobody hands you the map. You think there was one road and you missed the exit.
There were five roads. I want you to see all of them.
Four forks, one direction. The plan broke every time; the destination never moved.
📍 Fork 1: After high school
The plan: MBBS → MD Cardiology. What happened: two marks short of a public university seat.
Here's what was genuinely available to me based on my entrance score:
Option
What it actually meant
Retake the entrance exam
One more year, no guarantee, high opportunity cost
Private university MBBS
The same degree, at a fee my family would have felt for a decade
Dental school
A real, respected clinical career — just not the one I'd imagined
Occupational therapy
Strong patient contact, rehabilitation-focused
Bachelor's in Physical Therapy
✓ What I chose
I chose physical therapy because of a single conversation. A professor told me something that redirected my entire life:
You can still specialize in cardio. Physiotherapy has a cardiopulmonary track.
That was it. That was the whole reason. One person took ten minutes to explain that the destination I wanted had more than one entrance.
What I'd tell you here: the option that looks like a downgrade is often just a different entrance to the same building. Before you write a field off, find one person inside it and ask where its doors lead.
📍 Fork 2: During my bachelor's
I started shadowing at a clinic in my second year. What made it valuable wasn't the technique I picked up — it was the room. A physical therapist, a nurse, an orthopedic surgeon, and an acupuncturist, all working on the same patients.
I learned more about how care actually gets delivered in that clinic than in any textbook. I learned that a treatment plan is a negotiation between four perspectives, and that each profession sees something the others can't.
Straight out of graduation, I landed as a consultant physiotherapist across three different hospitals. A different condition every single day — neurological, orthopedic, cardiac, post-surgical.
That was the period that made me sure. Not sure about a job title — sure about the kind of problem I wanted to spend my life on.
What I'd tell you here: shadow early, and shadow somewhere with a mixed team. A single-discipline clinic teaches you a job. A multidisciplinary one teaches you the landscape.
📍 Fork 3: The master's
The plan: MSc in Cardiopulmonary Physiotherapy in India. What happened: I moved to the United States for a master's in Kinesiology and Exercise Science.
This is the fork where things stopped going according to my plotting and planning, and I want to be honest that it didn't feel like an upgrade at the time. It felt like a detour.
My reasoning for taking it: I could still go deep on exercise science, and still work toward cardiac and neurological populations. The vehicle changed; the direction didn't.
Then, during that program, I met the CPET machine.
Cardiopulmonary exercise testing sits exactly where I'd always been trying to get to. It's cardiology, pulmonology, and muscle metabolism in one test. You put someone on a cycle ergometer, measure gas exchange breath by breath, and the data tells you which system is failing and why. It's the closest thing physiology has to a unified field test.
I didn't plan for it. I wasn't looking for it. It was sitting in a building I'd walked into for other reasons.
What I'd tell you here: your interest will get more specific than your plan was. Leave room for that. A program is worth taking if it puts you in rooms where the thing you don't know about yet might be waiting.
📍 Fork 4: After the master's
By graduation I had a genuinely wide set of doors, and I want to lay all of them out, because this is the fork where most exercise science and physiotherapy graduates get stuck:
Sit for the PT licensure exam — practice clinically in the US
DPT school — the longer route to full US practice rights
PhD — the research-independence track
Clinical exercise physiologist — direct patient testing and rehabilitation
Clinical research certification courses — a targeted route into regulatory and trial operations
✓ Research associate + clinical exercise physiologist — what I chose
I went toward research in large part because my thesis had already pulled me into regulatory work, and I found I liked it more than I expected.
Today I run CPETs, interpret 9-panels, and do core-lab quality control for multicenter trials.
Every one of those six options was a real career. None of them was wrong. The reason I list them is that when I was standing there, I could only see two.
💡 The one rule that actually got me here
Never say no to a field before you've spent time inside it.
Not "before you've read about it." Not "before you've heard what it pays." Before you've been in the room — shadowed, talked to someone doing it, watched a normal Tuesday in that job.
Physical therapy was my consolation prize until I stood in that clinic. Kinesiology was a detour until I stood in front of a metabolic cart. Research was a fallback until I sat with the data.
Every door I walked through was one I nearly dismissed from the outside.
❤️ What's next
My heart is still in cardiology. That part never moved.
I don't know the exact route yet — I've stopped pretending I can plot these things — but I know the destination: working with cardiac patients, with CPET at the center of it. That much I'm certain about.
Which is a fitting place to end, because it's the same certainty I had at 17. The plan changed four times. The direction never did.
🎓 If you're the student in this story
If you're sitting with a score that doesn't match your plan, or a degree you're not sure what to do with, here's what would have helped me:
Write down every option, including the ones you've already dismissed. You'll usually find you were only seriously considering two.
Find one person inside each option. Ten minutes with someone doing the job beats ten hours of reading about it.
Ask where a field's doors lead, not just what it is. Physiotherapy wasn't my goal — but it had a cardio track, and that changed everything.
Judge a program by the rooms it puts you in, not just the credential at the end.
Accept that your plan will break. Mine broke at every single fork. The direction survived all four breaks.
I'm happy to help if you're standing at one of these forks — reach out. I remember exactly what it feels like to be there.
What did you want to be as a kid, and where did you actually land? I'd genuinely like to know.
Research vs. Clinical Exercise Physiologist: Two Paths, One Mission
By Mandeepa · 5 min read
Most people think all exercise physiologists do the same work. But there's a significant difference between a research exercise physiologist and a clinical exercise physiologist — in daily responsibilities, mindset, tools, and ultimate impact.
🏥 The Clinical Exercise Physiologist: Treating Patients
A clinical exercise physiologist focuses on treating patients — designing and supervising exercise programs for people living with chronic conditions such as heart disease, type 2 diabetes, obesity, or those recovering from cardiac events, surgery, or cancer treatment.
Their day is structured around people. They conduct stress tests and ECGs, lead cardiac rehabilitation sessions, monitor patient progress, and adjust exercise prescriptions based on individual responses. The goal is measurable improvement in a patient's health, function, and quality of life — often within weeks or months.
Rehab & exercise therapy for chronic conditions
Stress tests & ECG monitoring
Patient recovery and functional improvement
Direct, immediate impact on health outcomes
🔬 The Research Exercise Physiologist: Discovering Science
A research exercise physiologist, on the other hand, focuses on understanding the science behind human physiology and disease. The work doesn't start with prescribing workouts — it starts with questions.
How does cancer treatment affect aerobic capacity?
Why does obesity alter metabolic flexibility?
What physiological signals predict cardiometabolic risk early?
To answer these questions, detailed physiological data is collected using advanced assessments:
Resting Energy Expenditure (REE) — understanding metabolic rate and substrate utilization at rest
Flow-Mediated Dilation (FMD) — assessing vascular endothelial function and cardiovascular health
FibroScan — evaluating liver stiffness and metabolic organ health
Each test helps us understand how the heart, lungs, metabolism, and vascular system respond under different conditions. Participants come not just as patients — but as partners in advancing science. Every dataset collected contributes to something bigger: better diagnostics, better prevention strategies, and better clinical care for future patients.
🔗 Two Paths, One Mission
Clinical exercise physiologists help patients recover today. Research exercise physiologists help shape how patients will be treated tomorrow.
Together, these two paths bridge the gap between clinical practice and scientific discovery. The clinician sees what's happening in real patients right now. The researcher asks why it's happening — and what we can do better. Neither path is more important than the other. Both are essential.
Being part of that research process — collecting the data that eventually changes how diseases are diagnosed and treated — is what makes this work incredibly meaningful.
Panel 9: VT vs. V̇E — The Breathing Pattern Plot Most Labs Gloss Over
By Mandeepa · 7 min read
This is part of an ongoing series breaking down the Wasserman 9-Panel Plot one panel at a time. This entry covers the VT vs. V̇E plot — the primary graphical window into a patient's ventilatory mechanics and breathing pattern during exercise.
Most labs glance at this one and move on. But the VT vs V̇E plot tells you how a patient is compensating — and that distinction matters clinically. It serves as the primary graphical window into a patient's ventilatory mechanics and breathing pattern during exercise.
📨 What This Plot Measures
Minute ventilation is the product of how deep a person breathes and how fast they breathe:
V̇E = VT × BF
Where BF (or RR) is the breathing frequency / respiratory rate.
This plot visualizes exactly how a patient meets the metabolic demand for increasing V̇E. In healthy individuals, the respiratory system optimizes the energetic work of breathing by adjusting VT and BF in distinct, predictable phases.
Normal VT vs. V̇E curve: tidal volume rises linearly during early-to-mid exercise, then plateaus at ~60% VC as breathing frequency (BF) takes over to drive further increases in minute ventilation.
📈 The Normal Three-Phase Response
When a healthy subject progresses through an incremental exercise test, the relationship forms a characteristic curve — often matching the Hey-McConnell relation:
Early-to-Mid Exercise (The Linear Phase): Initially, the increase in V̇E is driven primarily by an increase in Tidal Volume (VT). The data points trend linearly upward. The patient is taking deeper breaths rather than rushing their breathing frequency.
The VT Plateau: As exercise approaches higher intensities, VT reaches a physical ceiling. In healthy individuals, this plateau typically occurs at roughly 50% to 60% of their Inspiratory Vital Capacity (IVC) or Forced Vital Capacity (FVC).
Late Exercise (The Tachypneic Shift): Once VT plateaus, any further increase in V̇E to match severe metabolic acidosis must be driven entirely by an increase in Breathing Frequency. Graphically, the curve bends horizontally to the right; V̇E increases substantially while VT stays flat.
Patients with restrictive defects (pulmonary fibrosis, severe chest wall deformities) cannot achieve a normal tidal volume.
Visual Pattern: The VT plateaus prematurely and shoots horizontally to the right. To meet the metabolic demands of exercise, the patient must rapidly shift to a high BF early in the test — producing a rapid, shallow breathing pattern.
2. Obstructive Lung Disease
In patients with COPD or severe airway obstruction, expiratory flow limitation prevents them from emptying their lungs completely before the next breath begins. Air becomes trapped progressively with each breath (dynamic hyperinflation).
Visual Pattern: VT may decrease or severely drop off at higher ventilation rates because the functional residual capacity is expanding, leaving less room for tidal exchange.
Not all abnormal patterns are structural; some are neuromuscular or psychogenic — e.g., hyperventilation syndromes, or dysfunctional breathing post-COVID-19.
Visual Pattern: Instead of a tight, clean, predictable curve, the data points appear highly erratic, chaotic, or scattered. You may see sudden, massive shifts in VT independent of steady metabolic changes, signaling an unstable respiratory drive.
🔵 The Bottom Line
This panel answers one question: did the ventilatory pump limit this patient, and if so, how? It cannot answer that question alone — it always needs spirometry (for VC, IC, MVV) and the other 8 panels for context. But used correctly, it is one of the most mechanistically rich plots in the entire CPET report, especially in populations like Long COVID where the mechanism of exercise intolerance is often genuinely uncertain.
Cite: Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir Res. 2022 Jan 12;23(1):9. doi: 10.1186/s12931-021-01895-6. PMID: 35022059; PMCID: PMC8754079
Treadmill vs. Cycle Ergometer: The Modality Is the Question
By Mandeepa · 6 min read
The choice between a treadmill and a cycle ergometer is often treated as a logistical preference — what's available, what the patient can manage, what the lab is used to. But the modality you select quietly shapes what your data actually means. It determines which physiological system reaches its ceiling first, and therefore which question your test can answer.
Treadmill vs. cycle ergometer across five decision axes — peak VO₂, limiting factor, ventilation & lactate, signal quality, and safety/accessibility.
📉 The 5–10% VO₂ gap has a clinical cost
Peak VO₂ runs roughly 5–10% higher on a treadmill than on a cycle, because walking and running recruit a larger active muscle mass than cycling does. More muscle drawing oxygen means a higher peak oxygen consumption.
The practical danger is in the comparison. If you test someone on a bike and compare their result against treadmill-derived reference norms, you can mislabel a healthy person as having reduced exercise capacity. Apples-to-apples matters: the modality of your data must match the modality of your norms.
🦵 Quadriceps fatigue is the bike's hidden ceiling
Cycling concentrates load on a smaller muscle mass, so patients often stop because their legs burn — not because their heart and lungs have maxed out. On the treadmill, the larger recruited muscle mass usually lets the central cardiopulmonary system express its true limit.
It's tempting to call leg fatigue a peripheral limitation "masquerading" as a cardiopulmonary one. But that framing undersells the bike. In the right clinical question — deconditioning, peripheral myopathy, suspected mitochondrial dysfunction — that peripheral limitation is the signal you're after. The treadmill maximizes the central number; the bike can isolate the peripheral cause.
💨 Ventilation and lactate behave differently by modality
At peak effort, cycling tends to provoke a steeper rise in pulmonary ventilation relative to oxygen consumption, with a higher V̇E/V̇CO₂ relationship. The likely driver is greater localized acidosis in the legs from concentrated muscle fatigue, which adds to ventilatory drive.
Peak blood lactate also tends to be somewhat lower on the treadmill following maximal exertion — consistent with the bike's more concentrated leg load generating more local acidosis. This is protocol- and population-dependent rather than a fixed rule, so it's best read as a tendency rather than a guarantee.
📟 Signal quality favors the bike
A stable torso means cleaner ECG tracings, easier cuff blood pressure readings, and feasible arterial and venous sampling. This is precisely why invasive CPET (iCPET) — with its pulmonary artery and radial arterial lines — lives on the cycle. You cannot run those catheters reliably on a moving, balancing patient.
🛡️ Safety and access flip the script
Treadmills demand balance, coordination, and reliable lower-limb function, which is challenging for frail, elderly, neurological, or orthopedic patients. The cycle is seated, steadier, and safer — which is why it dominates in deconditioned and high-risk populations where a treadmill simply isn't viable.
🧬 The mechanism beneath the numbers
The 5–10% VO₂ gap isn't an arbitrary correction factor — it falls directly out of the Fick principle. VO₂ is the product of cardiac output and arteriovenous oxygen difference (a−vO₂). Running recruits the large gluteal, hamstring, and calf groups alongside the quadriceps, plus postural and arm musculature. That broader recruitment increases venous return and stroke volume, while a larger mass of metabolically active tissue widens the a−vO₂ difference. Both terms of the Fick equation are pushed higher, so peak VO₂ climbs.
On the cycle, the quadriceps do a disproportionate share of the work. Local intramuscular pressure during the pedal stroke can transiently impede perfusion, so the limiting factor shifts toward peripheral oxygen delivery and extraction in a single muscle group rather than central pump capacity. This is exactly why the bike can unmask a peripheral problem the treadmill would compensate around — the same property that lowers its peak number makes it diagnostically sharper for certain questions.
⚙️ Protocols aren't interchangeable either
Modality is only half the decision — the ramp protocol matters just as much. The goal in most clinical CPET is a test that reaches volitional maximum in roughly 8–12 minutes. Too short and you under-sample the submaximal data; too long and peripheral fatigue or boredom ends the test prematurely.
Cycle ramp protocols allow precise, continuous work-rate increments (e.g. 10–25 W/min), which makes the VO₂/work-rate slope and the anaerobic threshold easier to define cleanly. Work rate is directly measured, not estimated.
Treadmill protocols (Bruce, modified Bruce, individualized ramp) change speed and grade in steps or ramps, but external work is inferred rather than measured directly — so the VO₂/work-rate relationship is less precise even though peak VO₂ is higher.
Matching the ramp to the patient is essential: a steep ramp on a deconditioned patient ends in leg fatigue before a cardiopulmonary limit; a shallow ramp on a fit athlete drags the test past 15–20 minutes and dampens the peak.
🧭 How to choose: a practical decision guide
When the modality isn't dictated by the patient's physical limitations, let the clinical question lead. A few rules of thumb:
Need the highest, most reproducible peak VO₂ (transplant evaluation, surgical risk stratification, athlete profiling)? → Treadmill, and compare against treadmill norms.
Need invasive measurements — arterial line, pulmonary artery catheter, repeated blood gases (suspected pulmonary hypertension, unexplained dyspnea, iCPET)? → Cycle, where the stable torso makes sampling feasible.
Need clean ECG and blood-pressure tracking (ischemia evaluation, arrhythmia, hemodynamic questions)? → Cycle for signal quality.
Frail, elderly, neurological, or orthopedic patient, or any balance/gait concern? → Cycle for safety — a fall risk outweighs a few percent of VO₂.
Trying to isolate a peripheral vs. central limitation (deconditioning, myopathy, mitochondrial disease)? → Cycle can deliberately expose the peripheral ceiling.
Serial testing on the same patient? → Keep the same modality and protocol every time — a within-patient change in modality can swamp a real change in fitness.
The treadmill answers "How high can you go?" The bike answers "Why do you stop?" One maximizes the number; the other explains it. The best labs don't default to one modality out of habit — they pick the one that matches the physiological question they're actually asking.
Panel 7: The Breath at the End — What Pₑₜ O₂ and Pₑₜ CO₂ Quietly Reveal
By Mandeepa · 7 min read
This is part of an ongoing series breaking down the Wasserman 9-Panel Plot one panel at a time — making each one simpler, more practical, and easier to apply clinically. Panel 7 tracks end-tidal O₂ and CO₂ partial pressures across rest, exercise, and recovery.
Panel 7 — PₑₜO₂ and PₑₜCO₂ versus time — is quietly one of the richest windows into pulmonary gas exchange in the entire 9-panel plot. While other panels report ventilation and oxygen consumption in aggregate, Panel 7 zooms in on the concentration of gases at the very end of each breath. That single detail changes everything about what it can tell you.
Panel 7 — PₑₜO₂ (green, rising) and PₑₜCO₂ (orange, falling) vs. time. Key landmarks: hypercapnia near AT, sustained PₑₜO₂ rise above AT, and hypocapnia during respiratory compensation.
The pressure gradients driving gas diffusion encode information about ventilation-perfusion (V̇/Q̇) matching. The more pronounced the ventilation relative to perfusion, the lower the PₑₜCO₂ and the higher the PₑₜO₂ — and vice versa in healthy lungs. Two curves, moving in opposite directions, narrating the same physiological story from different angles.
📈 PₑₜO₂ — Reading the Oxygen Curve
Rest to AT: At the start of exercise, end-tidal O₂ levels gradually fall. Working muscles are extracting more oxygen from the blood, and the air remaining in the lungs at the end of each breath has progressively less O₂ left in it. This decline is the expected, healthy response — the body is efficiently meeting its rising demand.
At the anaerobic threshold (AT): PₑₜO₂ reaches its nadir — its lowest point. This is the physiological "sweet spot." Muscles are extracting the maximum amount of O₂ relative to how much the person is breathing. Ventilation and metabolism are in near-perfect balance. Identifying this nadir is one of the V-slope method's most useful cross-checks: when PₑₜO₂ bottoms out at the same moment PₑₜCO₂ peaks, the AT call is highly confident.
The PₑₜO₂ nadir and PₑₜCO₂ peak occurring simultaneously at AT is one of the most reliable confirmatory signs in the entire 9-panel plot. When they align, trust your threshold call.
Note: PₑₜCO₂ should remain roughly constant at that point for the V-slope method to hold.
Above AT: PₑₜO₂ begins its sustained rise. The ventilatory system starts outpacing metabolic demand — more fresh air is brought in per breath than the muscles can utilize. This upswing is one of the V-slope method's most useful cross-checks for threshold identification, and it persists through peak exercise and into recovery.
📉 PₑₜCO₂ — Tracking the CO₂ Curve
When you look at PₑₜCO₂ during a CPET, you are tracking the concentration of CO₂ at the very end of exhalation — a non-invasive surrogate for arterial CO₂ (PaCO₂). The two track each other closely in healthy lungs, which is what makes Panel 7 so diagnostically valuable.
Rest to AT: PₑₜCO₂ rises gradually. As metabolic activity increases, CO₂ production rises, and the lungs fill more efficiently — raising the concentration in expired air. This reflects the body's growing metabolic output being matched by proportional ventilatory increases.
At AT: PₑₜCO₂ reaches its peak. In healthy adults, this typically falls between 35–45 mmHg. This is the point of maximal alveolar efficiency — the moment when CO₂ production and ventilatory clearance are most balanced.
Above AT: PₑₜCO₂ stabilizes or begins a slight decline. Ventilation starts increasing more rapidly than CO₂ production, gradually diluting the end-tidal concentration.
At VT2 (Respiratory Compensation Point): A sharp decline in PₑₜCO₂. The body has entered respiratory compensation — hyperventilation kicks in to blow off the excess CO₂ accumulating from anaerobic metabolism and combat worsening metabolic acidosis. The end-tidal CO₂ concentration drops steeply as alveolar ventilation surges beyond CO₂ output.
🔴 What Abnormal Patterns Reveal
🔻 PₑₜO₂ falling at exercise onset → exercise-induced hypoxaemia or right-to-left shunting. The lungs are failing to load O₂ adequately onto hemoglobin, so end-tidal O₂ drops rather than rising with ventilation.
🔺 Abrupt PₑₜO₂ rise at exercise onset → nonspecific or psychogenic hyperventilation. Fresh air floods the alveoli before metabolic demand justifies it, pushing end-tidal O₂ up immediately.
🔻 Significant PₑₜCO₂ drop during exercise → V̇/Q̇ mismatch and/or hyperventilation. Dead space is high, CO₂ is being washed out faster than it's produced, or both.
🔺 Progressive PₑₜCO₂ rise throughout exercise → alveolar hypoventilation. Think severe COPD, obesity hypoventilation syndrome, or neuromuscular disease — conditions where ventilatory drive or capacity cannot match CO₂ output.
⚠️ A Note on Precision
End-tidal values approximate arterial values — but they are not identical, and the difference matters clinically. The gap between alveolar and arterial gas tensions — quantified as the P(A-a)O₂ gradient and the P(a-ET)CO₂ gradient — can only be measured with simultaneous arterial blood gas sampling.
In healthy lungs, PₑₜCO₂ closely approximates PaCO₂ and the P(a-ET)CO₂ gradient is near zero. As V̇/Q̇ mismatch worsens — as in pulmonary hypertension, heart failure, or chronic lung disease — dead space ventilation increases, the gradient widens, and end-tidal values diverge from true arterial values.
End-tidal data gives you the pattern. Arterial blood gas analysis gives you the magnitude.
Panel 7 is where you identify the signal. Invasive measurement is where you quantify the severity.
Coming Up: Panels 2–6 & 8–9
Each panel in the Wasserman plot adds a distinct physiological layer. Future posts will continue the series — from the VE/VCO₂ slope in Panel 5 to the O₂ pulse curve in Panel 3. If Panel 7 is the breath at the end, those panels explain what drove it there.
Reference: Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir Res. 2022 Jan 12;23(1):9. doi: 10.1186/s12931-021-01895-6. PMID: 35022059; PMCID: PMC8754079.
Wasserman 9-Panel Plot — Panel 8: The Effort Validator
By Mandeepa · 8 min read
Most clinicians look at one number from Panel 8: did the patient hit RER ≥ 1.10 at peak? That single threshold tells you whether the test was maximal. But Panel 8 tells a much richer story if you follow the shape of the curve, not just the endpoint.
📐 What Is RER?
The Respiratory Exchange Ratio (RER) — sometimes called the Respiratory Quotient (RQ) during steady-state conditions — is the ratio of carbon dioxide output (V̇CO₂) to oxygen uptake (V̇O₂), measured in expired gas:
RER = V̇CO₂ / V̇O₂
It reflects which fuel source the body is burning, identifies the anaerobic threshold, and confirms whether a patient achieved maximal effort during testing.
At rest and during low-intensity exercise, the body runs primarily on fat oxidation, producing less CO₂ per unit of O₂ consumed. As intensity rises, the fuel mix shifts toward carbohydrates — and above the anaerobic threshold, the buffering of lactic acid by bicarbonate floods the system with extra CO₂, driving RER above 1.0.
Confirms maximal effort — the gold standard criterion
< 1.05 at peak
Suggests submaximal effort — poor motivation, early fatigue, orthopedic limitation
📈 The Normal RER Curve — What to Expect
A typical healthy CPET tracing starts with RER around 0.80–0.85 at rest. It rises gradually through low-intensity exercise as the carbohydrate contribution grows, then accelerates sharply as anaerobic metabolism kicks in above the AT. At peak exertion it crosses 1.0 and ideally reaches ≥ 1.10. In early recovery it drops quickly as CO₂ production falls and oxygen consumption remains elevated (EPOC).
⚡ Abrupt Rise in RER — What Caused It?
Mid-test spike (expected): As exercise intensity increases, the metabolic shift from aerobic to anaerobic metabolism causes muscles to produce lactic acid rapidly. The body buffers this acid using bicarbonate, generating CO₂ as a by-product. This sudden flooding of CO₂ causes V̇CO₂/V̇O₂ to spike sharply past 1.0 — and this inflection point is how we identify the ventilatory anaerobic threshold (VAT).
Early-test spike (abnormal): An abrupt RER rise during warm-up or low-intensity exercise is a red flag. Two primary causes:
Exercise-induced right-to-left shunt — structural cardiovascular issues such as a patent foramen ovale (PFO), where deoxygenated blood bypasses the lungs, causing an immediate erratic shift in gas exchange dynamics.
Acute hyperventilation — an anxious patient breathing rapidly and shallowly mechanically flushes CO₂ stored in the lungs, creating an artificial temporary RER spike even though the muscles are barely working.
When exercise suddenly stops, VO₂ drops rapidly as muscular demand ceases. But the lungs continue to exhale residual VCO₂ built up from peak exertion. This causes a brief post-exercise RER overshoot — a spike just after termination. This is actually a sign of good cardiorespiratory fitness and strong vascular efficiency. It means the cardiovascular system was genuinely stressed and is now efficiently clearing the metabolic debt.
🔴 RER < 1 Throughout — Pattern Recognition
Pattern
Mechanism
Poor effort / submaximal test
No significant anaerobic metabolism → no lactate buffering → no excess CO₂ → RER stays below 1.0. Tracing shows low peak VO₂, low HR, flat Wasserman plot.
Severe lung disease (ventilatory limitation)
Patient is genuinely limited by inability to ventilate — VE hits its ceiling (low breathing reserve), symptoms overwhelm before anaerobic metabolism takes hold. RER never rises because intensity never got high enough.
Myopathy
Muscle disease causes fatigue at low absolute workloads — before anaerobic metabolism dominates. The muscles give out, not the lungs.
The key distinction: poor effort and myopathy both keep RER low, but myopathy typically presents with low peak VO₂ alongside disproportionately early fatigue and preserved ventilatory reserve. Context across all 9 panels matters.
🫁 Delayed RER Drop in Early Recovery
This is a classic sign of severe COPD. Patients with advanced obstructive disease have significant air trapping, dynamic hyperinflation, and profoundly inefficient alveolar ventilation. When exercise stops:
VO₂ drops at its normal rate (metabolic demand decreases).
VCO₂ remains elevated for much longer — the patient cannot effectively clear CO₂ accumulated in poorly ventilated lung units and in the blood.
Net effect: RER stays elevated — sometimes above 1.0 — well into recovery. Think of it as a "CO₂ hangover." You will also often see low PₑₜCO₂ throughout (dead space ventilation) and a markedly elevated VE/VCO₂ slope. The delayed RER recovery is congruent with all of these findings.
⬇️ Rapid RER Drop in Recovery — What It Means
When exercise stops after a genuinely high-intensity effort:
VCO₂ falls quickly — CO₂ production drops sharply as the bicarbonate buffering reaction winds down and, if ventilatory mechanics are intact, CO₂ is cleared efficiently.
Result: VCO₂/VO₂ = RER drops fast in early recovery, sometimes dipping below 1.0 or even below resting values transiently. The bigger the O₂ deficit incurred (the longer the patient sustained effort above AT), the more pronounced this recovery dip.
Long COVID connection: Some post-COVID patients show blunted EPOC and attenuated recovery VO₂ trajectories — potentially reflecting mitochondrial dysfunction or microvascular abnormalities impairing the normal oxidative repayment process. Tracking recovery RER and VO₂ kinetics may be a valuable window into this mechanism.
〰️ Erratic RER Curve — Fragmented Gas Exchange
An irregular, highly fluctuating RER curve is the primary indicator of hyperventilation or dysfunctional breathing patterns. The RER calculation relies heavily on breath-by-breath VCO₂. Any disruption — a sigh, a gasp, breath-holding, or hyperventilation — mechanically alters alveolar CO₂ and spikes or crashes the ratio artificially.
Common causes:
Psychogenic anxiety — tight mask or mouthpiece causes erratic, unstable breathing, producing artificial spikes and drops throughout the test.
Pathological breathing patterns — exercise-induced asthma, vocal cord dysfunction, or periodic breathing cause unstable air exchange that visually fragments the RER data.
Mask leak or moisture buildup — ambient air mixing with exhaled breath, or condensation blocking sampling lines, causes the gas analyzer to miscalculate both VO₂ and VCO₂ — producing a jagged, erratic tracing. Always rule out equipment artifact first.
Calibration error — inadequate pre-test sensor calibration can make the analyzer hyper-sensitive or sluggish, generating noisy data throughout.
Exercise Oscillatory Ventilation (EOV) in Heart Failure: In specific clinical populations, a rhythmic, wave-like erratic RER curve is a profound diagnostic signal. EOV — characterized by cyclical fluctuations in breathing volume and gas exchange — creates a distinct rolling pattern. This is a strong predictor of advanced heart failure or significant cardiac dysfunction and should be flagged and escalated.
References: Wasserman K, et al. Principles of Exercise Testing and Interpretation. 5th ed. Lippincott Williams & Wilkins; 2011. | Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir Res. 2022;23(1):9. doi:10.1186/s12931-021-01895-6.
VO2 Kinetics: What the Rise Tells You Before the Peak Does
By Mandeepa · 6 min read
Most conversations about VO2 start and end with one number: VO2peak. But VO2peak only tells you where someone landed. VO2 kinetics tells you how they got there — and that story often carries more clinical and physiological information than the peak value alone.
VO2 kinetics is the time course of oxygen uptake when exercise demand changes — classically studied at the onset of a constant-work-rate bout. Plot VO2 against time from the moment work starts, and you get a curve with three distinct phases.
Oxygen uptake response after a step increase in work rate, across the three exercise intensity domains.
The three phases
Phase I — the cardiodynamic phase
The first 15–20 seconds. VO2 jumps quickly, but this isn't muscle metabolism changing yet — it's the abrupt rise in cardiac output pushing more pulmonary blood flow past the lungs. This delay before the "real" signal starts is the time delay (TD).
Phase II — the primary component
This is the phase that actually reflects what's happening in the exercising muscle. VO2 rises in a roughly exponential curve as oxidative phosphorylation ramps up to meet demand. It's characterized by the time constant (τ) — the time it takes to reach 63% of the way to the eventual steady-state value.
A faster τ means the muscle is adjusting its oxidative metabolism quickly and efficiently. A slower τ means a bigger reliance on anaerobic pathways early in the bout, a larger oxygen deficit, and often reduced exercise tolerance in daily activities that involve frequent starts and stops rather than one long steady effort.
Phase III — where the story splits by intensity domain
What happens next depends entirely on how hard the exercise is:
Domain
What VO2 does
Everyday example
Moderate
Settles cleanly into steady state, matched to the work rate.
A comfortable walk or an easy jog you could hold for an hour.
Heavy
Appears to steady, then creeps upward again — the VO2 slow component — before eventually reaching a delayed, higher steady state.
A brisk tempo run where breathing keeps getting harder even though your pace hasn't changed.
Severe
Never steadies at all. VO2 climbs continuously toward VO2max until the person can't sustain the work rate and stops.
An all-out hill sprint or the final push of a race — you don't settle in, you just run out of runway.
The slow component is thought to reflect progressive recruitment of less oxidatively efficient type II fibers as more efficient fibers fatigue, along with rising metabolite accumulation. It's a marker that the exercise has crossed into a domain where "steady state" is a moving target.
Why it matters
VO2peak tells you the ceiling. Kinetics tells you the efficiency of getting there. Two people can post an identical VO2peak and tell very different stories: one reaches steady state quickly and comfortably, the other drags through a slow, effortful climb every time demand increases — more anaerobic cost, more perceived effort, less tolerance for repeated bouts of daily activity. That distinction is invisible if you only ever look at the peak.
Reading kinetics well also depends on how the test is run. τ is a small, noisy signal buried in breath-by-breath data, so it needs a clean step transition — a true, unannounced change from baseline to a constant work rate, held long enough to reach steady state or its slow-component plateau. Warm-up ramps, unstable baselines, or work rates that drift instead of stepping cleanly will blur TD and τ past the point of being useful. Ideally kinetics are captured over repeated identical transitions and averaged, since a single bout carries too much breath-by-breath noise to trust on its own. Get the protocol right, and the rise of the curve becomes just as informative as where it ends.
Do you look at kinetics in your own CPET reads, or mostly focus on peak values? Curious how this shows up across different labs.
Every CPET report has a peak VO2 number on it. Clinicians circle it, patients ask about it, and it often becomes the single line that "summarizes" the whole test.
But peak VO2 isn't one number — it's a lens, and the lens you choose changes what the test is telling you. Two patients can post the same peak VO2 and be living completely different physiological stories. Here's how to read past the headline number.
Quick reference: eight ways to read VO2
VO2 form
Formula / basis
What it tells you
Watch out for
Absolute VO2
L/min, raw
Total metabolic/cardiac demand; functional capacity for real-world load
Not comparable across body sizes
Relative VO2
mL/kg/min (÷ total body weight)
Standard fitness metric, cross-comparable
Penalizes fat mass, not just fitness
VO2/kg FFM
mL/kg fat-free mass/min
True cardiovascular capacity, corrected for adiposity
Effort-independent, reproducible; useful when peak effort isn't reached
Not a measure of ceiling capacity
VO2max vs. VO2peak
Max = plateau + secondary criteria; Peak = highest value achieved
Whether the true physiological ceiling was reached
Terms often used interchangeably in error
ΔVO2/ΔWR slope
Change in VO2 per change in work rate (~10 mL/min/watt normal)
Cardiovascular responsiveness across the test, not just at the end
A flattening slope can precede a normal-looking peak VO2
1. Absolute VO2 (L/min)
This is oxygen consumption in raw terms — no normalization to body size. It reflects total metabolic and cardiac demand, which makes it genuinely useful for functional capacity questions: can this person carry a load, climb with gear, sustain an occupational task.
The limitation is obvious once you say it out loud: absolute VO2 scales with body size. A larger individual can post a higher absolute VO2 while carrying comparatively poor fitness. On its own, this number tells you what the body produced, not how well it produced it.
2. Relative VO2 (mL/kg/min)
Divide absolute VO2 by total body weight and you get the standard fitness metric — the one used for cross-comparison between individuals, and the one most reference equations are built around.
The catch: this normalization treats all body mass equally, but fat mass barely consumes oxygen. So in higher-adiposity patients, relative VO2 can look artificially low — not because the cardiovascular system is failing, but because the denominator is inflated by tissue that isn't metabolically demanding in the same way lean mass is. Same underlying fitness, different number, depending on body composition.
3. VO2/kg Fat-Free Mass
This is the correction: normalize to fat-free mass instead of total body weight. It removes the adiposity penalty described above and, in populations where body composition is a variable rather than a constant — pediatric obesity being a clear example — this is often the number that reveals what's actually happening cardiovascularly, once the confound of excess fat mass is stripped out.
Clinical pearl: If relative VO2 and VO2/kg FFM tell noticeably different stories on the same patient, that gap is itself clinically informative.
4. Percent Predicted VO2peak
Measured VO2peak divided by a predicted value from a reference equation (Wasserman, FRIEND registry, and Jones equations are common choices, each built from different populations). This is the number that puts a raw VO2 value in context against what's expected for that person's age, sex, and height.
Generally, values above roughly 84% of predicted are considered normal, with values below about 80% flagging reduced functional capacity. But this percentage is only as trustworthy as the equation behind it — switching reference equations can meaningfully shift where a patient lands, which is worth stating explicitly rather than treating the percentage as an absolute truth.
5. METs
VO2 divided by 3.5 mL/kg/min converts the physiology into a unit that translates outside the lab: METs. This is the number that does the most work in a conversation with a patient or a referring provider — "4 METs" maps onto recognizable daily activity, like climbing a flight of stairs, in a way that mL/kg/min never will. It's also a standard input for surgical clearance and cardiac risk stratification discussions.
6. VO2 at VT1 and VT2
Peak VO2 requires the patient to reach — or approach — true exhaustion. VO2 at the ventilatory thresholds does not. Because these submaximal values are effort-independent, they're often more reproducible, and in populations who can't or won't reach a true peak effort — pediatric patients, deconditioned patients, cardiac populations — VO2 at VT1/VT2 can end up being the more clinically actionable value on the whole report.
7. VO2max vs. VO2peak
These terms get used interchangeably far more often than they should. True VO2max requires a plateau — VO2 failing to rise further despite an increasing work rate — plus secondary criteria such as RER ≥1.10, heart rate near predicted maximum, and RPE ≥17–18. Without a plateau, what you have is VO2peak: the highest value the patient achieved, not necessarily the physiological ceiling.
The distinction matters because "peak" and "max" imply different things about how close the test got to the true limit — and that difference shapes how the rest of the report should be interpreted.
8. ΔVO2/ΔWR — the VO2–work rate slope
This isn't a single value at all — it's a relationship. Normal is approximately 10 mL/min/watt: as work rate climbs, VO2 should climb proportionally. A flattening slope partway through the test suggests the cardiovascular system is failing to keep pace with increasing demand — a Fick-limited pattern — regardless of where peak VO2 ultimately lands.
Clinical pearl: Two patients can hit an identical peak VO2 with very different slopes, and the slope is often the earlier warning sign.
The takeaway
Peak VO2 is a headline, not the whole article. The same number can represent excellent fitness in fat-free mass terms and reduced capacity in relative terms; a true physiological ceiling in one patient and an effort-limited peak in another; a smooth cardiovascular response or a flattening one on the way there.
Reading VO2 well means asking which of these eight lenses you're actually looking through — and checking whether the others agree.
Which of these gets overlooked most often in your practice? I'd like to hear where you've seen the "same number, different story" pattern show up.
Wasserman 9-Panel Plot — Panel 1: Six Things Most Clinicians Miss
By Mandeepa · 6 min read
If you work in cardiology, pulmonology, exercise physiology, or sports medicine, the Wasserman 9-Panel Plot can feel overwhelming when you first start interpreting CPET. Instead of explaining all 9 panels together, I’ll be breaking them down one by one—making each panel simpler, practical, and easier to apply in real cases.
DAY 1 (Panel 1) - Most clinicians look at peak VO₂ and move on but, Panel 1 of a CPET has 6 things worth reading — and most of them get missed.
Here's the quick breakdown:
1️⃣ Peak VO₂ — aerobic ceiling and survival predictor. Only valid if effort is maximal (RER ≥ 1.10).
2️⃣ ΔVO₂/ΔWR slope — should be ~10 mL/min per watt. Below 8? Impaired O₂ delivery. Think heart failure, PAD, pulmonary vascular disease.
3️⃣ VO₂ early flattening or plateau mid-exercise — the cardiovascular system hit its ceiling. More watts, no more O₂. Classic cardiac limitation.
4️⃣ Post-exercise VO₂ overshoot — afterload drops at exercise termination, stroke volume briefly spikes. A subtle cardiovascular sign.
5️⃣ Slow VO₂ recovery — large O₂ deficit during exercise = poor oxidative capacity or severe impairment.
6️⃣ Oscillatory VO₂/VCO₂ patterns — not artifact. Exercise oscillatory ventilation (EOV) at submaximal loads is a marker of chronic heart failure with independent prognostic significance.
EOV is strongly associated with heart failure with reduced ejection fraction, where unstable cardiac output drives a Cheyne-Stokes-like cycle: output drops → peripheral chemoreceptors sense CO₂ rise → ventilatory surge → CO₂ falls → ventilation overshoots → and the cycle repeats. EOV has been shown to be an independent predictor of mortality in heart failure patients, even when peak VO₂ is relatively preserved.
One panel. Six data points. Enormous clinical value. The rest of the 9-panel plot explains WHY. Panel 1 tells you WHAT.
Cite: Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir Res. 2022 Jan 12;23(1):9. doi: 10.1186/s12931-021-01895-6. PMID: 35022059; PMCID: PMC8754079.
Wasserman 9-Panel Plot — Panel 1: Six Things Most Clinicians Miss
By Mandeepa · 6 min read
If you work in cardiology, pulmonology, exercise physiology, or sports medicine, the Wasserman 9-Panel Plot can feel overwhelming at first. Instead of explaining all 9 panels together, this series breaks them down one by one — making each panel simpler, practical, and easier to apply in real cases.
Most clinicians look at peak VO₂ and move on. But Panel 1 of a CPET has 6 things worth reading — and most of them get missed.
Panel 1 — VO₂ (solid) and VCO₂ (dashed) vs. time. Key landmarks: Point B (start of exercise), AT zone, VO₂ oscillations, plateau, and Point E (peak / end of exercise).
Here's the quick breakdown of all six data points hidden in Panel 1:
Peak VO₂ is the aerobic ceiling — the maximum rate at which the body can consume oxygen. It is also a powerful survival predictor in heart failure, pulmonary hypertension, and post-cardiac surgery populations. Critical caveat: it is only valid if effort is truly maximal, defined by an RER ≥ 1.10. Without confirming effort, a "low" peak VO₂ may simply reflect submaximal exertion rather than true impairment.
2️⃣ ΔVO₂/ΔWR Slope — The Oxygen Efficiency Index
The ΔVO₂/ΔWR slope should be approximately 10 mL/min per watt in a healthy individual. A value below 8 mL/min/W signals impaired oxygen delivery and should immediately raise suspicion for:
The slope in the example above is 11.0 mL/min/W — within normal range, telling us O₂ delivery is efficient during the loaded phase of exercise.
3️⃣ VO₂ Early Flattening or Plateau Mid-Exercise
When VO₂ stops rising despite increasing workload — the cardiovascular system has hit its ceiling. More watts go in, but no more O₂ comes out. This is the classic signature of cardiac limitation: the heart can no longer increase stroke volume or cardiac output to meet muscular demand. Look for the "plateau" annotation in Panel 1 — it's one of the most underread signs in the entire 9-panel plot.
4️⃣ Post-Exercise VO₂ Overshoot
At exercise termination, afterload drops suddenly. For a brief window, stroke volume can actually spike above peak values — producing a characteristic VO₂ overshoot in the immediate recovery phase. This is a subtle but real cardiovascular sign, reflecting the hemodynamic unloading that occurs when external work ceases. It's easy to dismiss as noise; it rarely is.
5️⃣ Slow VO₂ Recovery Kinetics
How quickly does VO₂ return to baseline after peak? A slow recovery reflects a large accumulated oxygen deficit during exercise — a marker of poor oxidative capacity or severe cardiopulmonary impairment. In heart failure patients, prolonged recovery kinetics correlate with worse prognosis independently of peak VO₂ itself.
The oscillations visible in the middle phase of this trace are not artifact. Exercise oscillatory ventilation (EOV) at submaximal loads is a clinically significant marker of chronic heart failure with independent prognostic significance.
The mechanism: unstable cardiac output drives a Cheyne-Stokes-like cycle —
Cardiac output drops → peripheral chemoreceptors sense CO₂ rise
Ventilatory surge follows → CO₂ falls
Ventilation overshoots → and the cycle repeats
EOV is strongly associated with heart failure with reduced ejection fraction (HFrEF) and has been shown to be an independent predictor of mortality in heart failure patients — even when peak VO₂ is relatively preserved.
One panel. Six data points. Enormous clinical value.
The rest of the 9-panel plot explains WHY. Panel 1 tells you WHAT.
Coming Up: Panels 2–9
Each panel in the Wasserman plot adds a new layer of physiological context. Future posts in this series will walk through each one — from the VE/VCO₂ slope in Panel 5 to the O₂ pulse curve in Panel 3. Stay tuned.
Reference: Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir Res. 2022 Jan 12;23(1):9. doi: 10.1186/s12931-021-01895-6. PMID: 35022059; PMCID: PMC8754079.
Panel 2 — HR (red) and O₂ pulse (blue) vs. time showing flat rise, plateau, and downsloping patterns.
O₂ pulse and heart rate kinetics: how the relationship between HR and oxygen delivery reveals the true mechanism behind exercise limitation.
In clinical exercise testing, the relationship between Heart Rate (HR) and Oxygen Pulse is a powerful indicator of cardiac function. While HR represents the chronotropic response, $O_2$ pulse ($VO_2/HR$) is a non-invasive surrogate for stroke volume and peripheral oxygen extraction.
HR reserve: The difference between predicted and actual peak heart rate. A high reserve may indicate pulmonary or effort-based limitation.
Flat rise or plateau in O₂ pulse: Often suggests a limitation in stroke volume, common in heart failure or valvular disease.
Downsloping O₂ pulse: Can be a sign of exercise-induced myocardial ischemia or severe cardiovascular impairment.
Reference: Glaab, T., & Taube, C. (2022). Practical guide to cardiopulmonary exercise testing in adults. Respiratory research, 23.
Wasserman 9-Panel Plot — Panel 3: Reading Between the HR Lines
By Mandeepa · 6 min read
Panel 3 — V-slope (VCO₂ vs. VO₂) and HR kinetics. The shaded corridor shows the normal heart rate response relative to oxygen uptake.
I used to think heart rate during exercise was simple: it goes up, you work harder, it comes down. Panel 3 of a CPET changed that.
Here's what the nine-panel plot taught me about HR that no textbook chapter ever did: HR doesn't just rise during exercise — it rises relative to VO₂. And that relationship has a normal corridor. A shaded band on panel 3 shows you the expected HR for every level of oxygen uptake. Your patient's actual HR curve either tracks within it, runs above it, or falls below it.
Above it: tachycardia for the workload. The heart is compensating for something — low stroke volume, poor O₂ carrying capacity, autonomic overdrive.
Below it: bradycardia for the workload. Each beat is doing more work. Athletic adaptation, beta-blocker effect, or — when peak VO₂ is also low — chronotropic incompetence.
Combined with the V-slope (the inflection in VCO₂/VO₂ that marks the anaerobic threshold), you now have two data streams on one plot: → When does aerobic metabolism give out? (V-slope AT) → Is the heart doing too much, too little, or just right to get there? (HR corridor)
In practice: A patient with HIV-related chronotropic incompetence might show HR running flat or below corridor at peak — the heart simply can't raise its rate, leaving large HR reserve.
A post-TB patient might show a normal corridor pattern — but exercise terminates early because the ventilatory system, not the heart, hits its ceiling first.
Same panel. Same axes. Two different stories.
This is why I find CPET endlessly fascinating — it's one of the few tests where mechanism, not just result, is directly visible.
Wasserman 9-Panel Plot — Panel 5: Balancing Breathing and Work
By Mandeepa · 6 min read
Panel 5 — V̇E (solid blue) and WR (dashed grey) vs. time. The red line represents the Maximal Voluntary Ventilation (MVV).
Panel 5 tracks the relationship between Minute Ventilation (V̇E) and Work Rate (WR). It is the primary tool for assessing if a patient's breathing is appropriate for their effort.
1. The V̇E curve
The blue line represents V̇E in liters per minute. In a normal individual, V̇E increases linearly with work rate until the anaerobic threshold, after which it increases disproportionately. Todetermine if the ventilatory response is "adequate," use the 9-point rule as a quick plausibility check:
The Formula: Each 25 W increase in work rate should require roughly 9 L/min of ventilation, plus an additional9 L/min for the resting baseline.
Example: At a total work rate of 100 W, the VE should be approximately 45 L/min (4 *9 + 9).
2. Ventilatory capacity vs. Demand
The red horizontal line is the Maximal Voluntary Ventilation (MVV), often calculated as FEV₁ × 40. The difference between peak V̇E and MVV is the Breathing Reserve. In healthy individuals, the breathing reserve is usually >15%, meaning the lungs are not the limiting factor for exercise. If the VE curve approaches or touches the MVV line, it suggests a ventilatory limitation to exercise.
3. 100% WR predicted
The dashed green line represents the 100% predicted work rate. This allows for a quick visual comparison of achieved vs. expected capacity. Reduced peak WR with preserved breathing reserve = cardiocirculatory limitation, not pulmonary.
Hyperventilation, anxiety, or high dead space ventilation
V̇E / WR slope > predicted
Reduced ventilatory efficiency, V̇/Q̇ mismatch
5. Patient Effort
The panel helps confirm if the patient reached a true symptom-limited maximum. If the VE continues to track linearly with work rate until the very end without any flattening or evidence of "running out of breath" (low breathing reserve), yet the patient stops, you may need to look at other panels (like Heart Rate in Panel 2) to see if the limitation was cardiovascular or perhaps due to leg fatigue/poor effort.
Next time you review a CPET, ask: Did the patient stop because they ran out of breath, or because their legs gave out? Panel 5 holds the answer.
Cite: Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir Res. 2022 Jan 12;23(1):9. doi: 10.1186/s12931-021-01895-6. PMID: 35022059; PMCID: PMC8754079
Beyond the Mask: What Invasive CPET Reveals That Non-Invasive Testing Cannot
By Mandeepa · 8 min read
Side-by-side comparison: what non-invasive vs. invasive CPET can and cannot measure directly.
Cardiopulmonary exercise testing has long been the gold standard for integrative physiological assessment. But for patients with unexplained exertional symptoms or complex cardiopulmonary disease, the standard test only tells half the story.
The Non-Invasive Ceiling
While standard, non-invasive CPET offers an incredible look at systemic exercise tolerance through gas exchange, ventilatory equivalents, heart rate, VO₂ kinetics, and work rate responses — it fundamentally treats the internal cardiovascular system as a black box. When peak VO₂ is reduced, we can identify where the system is failing, but we cannot directly measure why the oxygen delivery chain breaks down at that specific link.
Non-invasive testing cannot isolate whether the breakdown is occurring because of central cardiac pumping failure, pulmonary vascular constriction, or peripheral muscle extraction defects. This is precisely the reason why invasive CPET was designed.
What Makes It "Invasive"
Exercise testing is performed on a stationary bicycle while hemodynamic monitoring is achieved via two catheters:
Pulmonary artery catheter — provides direct measurement of right atrial pressure, pulmonary artery pressure, mixed venous oxygen saturation (SvO₂), and Fick cardiac output.
Radial or femoral arterial line — enables continuous arterial blood pressure monitoring and serial arterial blood gas sampling.
Both lines remain in place throughout the entire protocol: from baseline (seated rest) → loaded exercise → peak exertion → early recovery.
The Fick Equation: From Estimation to Measurement
Everything in iCPET traces back to the Fick principle:
VO₂ = CO × C(a-v)O₂
In non-invasive CPET, VO₂ is directly measured from gas exchange, but cardiac output (CO) must be estimated or inferred. In iCPET, all three variables are independently measurable — which means we can answer the question that conventional CPET cannot:
Is reduced peak VO₂ driven by a failure of oxygen delivery (low CO) or a failure of oxygen extraction (low a-vO₂ difference)?
Side-by-Side Comparison
Variable
Non-Invasive
Invasive
Peak VO₂
✓ Direct
✓ Direct
VE/VCO₂ slope
✓ Direct
✓ Direct
Cardiac output
✗ Estimated
✓ Thermodilution / Fick
Pulmonary artery pressures
✗ Unavailable
✓ Continuous
PCWP / pulmonary venous pressure
✗ Unavailable
✓ Continuous
Mixed venous SvO₂
✗ Unavailable
✓ Continuous
a-vO₂ difference
✗ Estimated
✓ Directly measured
Exercise-induced pulmonary hypertension
✗ Cannot diagnose
✓ Primary diagnostic tool
Preload reserve (Frank-Starling)
✗ Unavailable
✓ PCWP vs. CO response
The Bottom Line
The Wasserman nine-panel plot tells you where the system fails. iCPET tells you why the system was always going to fail at that point — and sometimes, it tells you something you never would have suspected.
Key references: Lewis GD et al. Physiological diagnosis of coronary microvascular disease using invasive CPET. Circulation. 2007. · Oliveira RKF et al. Usefulness of invasive CPET in the evaluation of dyspnea. JACC Heart Fail. 2019.
The Four-Minute Rule: Why the Norwegian 4×4 Is the Gold Standard for VO₂max
By Mandeepa · 6 min read
If you’ve spent any time around endurance training or CPET, you’ve heard the claim: the Norwegian 4×4 is the most effective protocol for improving VO₂max. It was developed and heavily researched by scientists at the Norwegian University of Science and Technology — most notably Jan Helgerud and Jan Hoff.
Four bouts of four minutes hard, followed by three minutes easy. It sounds simple — but every number in it is solving a specific physiological problem.
Start with what actually limits VO₂max
The whole logic flows from the Fick equation:
VO₂max = Q̇max × (a–v̄O₂ difference)
In most reasonably trained people, the ceiling sits on the delivery side — specifically maximal stroke volume. Peripheral extraction is already running near its limit; the heart’s pumping capacity is the lever with the most room to move. Pushing past 95% doesn’t increase stroke volume further, because the heart beats so fast that diastolic filling time shortens and stroke volume plateaus or even drops. So the training question becomes very precise: how do you accumulate the most time with the heart working at its stroke-volume ceiling? That single question explains the entire protocol.
What are 4×4 intervals?
The 4-minute work bout is the clever part. Because of VO₂ on-kinetics, it takes roughly 90–120+ seconds to climb into the VO₂max zone. Shorter intervals at the same intensity keep cutting you off before you’ve truly arrived — you pay the kinetic “tax” every rep and bank little time at the top. Four minutes lets VO₂ ramp up and then dwell near peak for the back half of the bout. That dwell time is the money.
The 85–95% HRmax intensity is the other half of the optimization. It’s high enough to demand near-maximal Q and maximal preload, but submaximal enough to be sustainable for four minutes. Go truly all-out (sprint/Wingate territory) and you hit peripheral and anaerobic limits long before you’ve loaded the heart for long enough — you’d be training a different system. The 4×4 deliberately sits at the intensity that taxes the delivery system maximally without capping duration.
The 3-minute active recovery is intentionally incomplete. HR drops to ~60–70%, metabolites clear enough to repeat, but VO₂ doesn’t fully return to baseline — so each subsequent rep “primes” and reaches the VO₂max zone faster than the first. Active rather than passive recovery keeps blood flow and VO₂ on-kinetics favorable for the next bout. And running it four times accumulates a session-level dose of high-VO₂ time that no single continuous effort at that intensity could match.
The evidence behind it
The empirical backbone is Helgerud and colleagues (2007). They compared the 4×4 and a short 15/15 protocol against long slow distance and threshold-continuous training — and crucially, they matched the protocols for total work. The high-intensity groups produced VO₂max gains of around 5–7% over eight weeks. The moderate-intensity groups produced essentially nothing.
The headline finding: total volume wasn’t the discriminating variable. Time spent near VO₂max was.
What’s actually adapting
Repeated near-maximal preload drives the chain of central adaptations that raise the ceiling: eccentric left-ventricular remodeling (a larger end-diastolic volume, and therefore higher stroke volume), improved contractility and calcium handling, plasma volume expansion, and the endothelial adaptations that come with sustained high shear stress. Over weeks, that’s a heart that pumps more blood per beat at max — exactly the side of the Fick equation that was holding VO₂max back.
How to actually run it
Warm up for 8–10 minutes until you’re lightly sweating.
4 minutes at roughly 85–95% of max HR — hard enough that talking is difficult.
3 minutes of active recovery at around 60–70% — easy, but keep moving.
Repeat for 4 work intervals total.
Cool down for 5 minutes.
Two to three sessions a week is plenty. Done honestly, this is demanding work, so build in real recovery between sessions — and if you have a cardiac or pulmonary history, get cleared before adding high-intensity intervals.
The takeaway
Four minutes isn’t magic. It’s the point where interval duration, sustainable intensity, and recovery pattern line up to maximize one thing: cumulative time at the cardiovascular ceiling. That’s the dose that moves VO₂max — and the 4×4 is simply the most elegant way anyone has found to deliver it.
Adaptations at a glance
Adaptation type
Specific physiological change
Impact on VO₂max
Central (the pump)
Left-ventricular remodeling, increased myocardial contractility, and increased total blood plasma volume.
Increases cardiac output: delivers more oxygenated blood to working muscles per minute.
Peripheral (the muscles)
Enhanced capillarization around skeletal muscle fibers and increased mitochondrial density / enzyme activity.
Increases a–vO₂ difference: improves the muscles’ ability to pull oxygen out of the bloodstream efficiently.
Your ANS is the maestro of CPET—here's how it conducts from rest to recovery
By Mandeepa · 10 min read
It is honestly one of the most beautifully orchestrated symphony of physiological changes we can witness in real-time. When we're watching a patient on a metabolic cart during a maximal incremental CPET, we aren't looking at gas exchange—we are watching a literal tug-of-war and handover between the parasympathetic (PNS) and sympathetic nervous system (SNS).
Visual guide: ANS regulation across the six phases of cardiopulmonary exercise testing — from parasympathetic dominance at rest to sympathetic supremacy at peak, with rapid parasympathetic restoration in recovery.
Here is exactly how the autonomic nervous system (ANS) pulls the strings across every single phase of that test:
1. Resting Baseline (Before the Pedals Turn)
Parasympathetic dominance: High vagal tone, normal HR variability
ANS state: Stable—this is the baseline to compare against
The moment the patient sits on the bike and faces the mouthpiece, the cerebral cortex triggers an anticipatory response, causing early vagal withdrawal
2. Unloaded Cycling & Early Incremental Phase (First 1–2 mins)
Once the test begins, the body has to rapidly adjust to the onset of movement.
HR spikes immediately—often before metabolic feedback even begins
This is pure central command (ANS anticipatory drive from the brain)
Parasympathetic withdrawal happens first (vagal brake release)
Sympathetic ramp-up follows closely behind
Group 3 and 4 muscle afferents (mechanoreceptors) sense mechanical stretch in the working limbs and immediately signal the medulla to suppress vagal activity and ramp up sympathetic drive
Clinical Pearl: If early HR response is blunted → suggests vagal dysfunction or beta-blocker effect
3. Progressive Increments (Steady Climbing Phase)
Once parasympathetic withdrawal is maximized, the SNS takes absolute control to meet the skyrocketing metabolic demand.
Sympathetic progressively dominates as workload increases
HR acceleration may suddenly increase (steeper slope) if ANS is responsive
Chronotropic incompetence shows here: If HR doesn't accelerate appropriately despite sympathetic drive, it suggests:
Intrinsic chronotropic dysfunction
Autonomic dysregulation
Beta-blocker masking
Sinus node disease
5. Peak Exercise (VO₂ max)
At the absolute peak of the incremental ramp, the SNS is operating at maximum capacity.
High sympathetic drive, paired with central command and peripheral chemoreceptor stimulation (sensing the dropping pH and rising CO₂), drives the massive increase in minute ventilation (VE) to its peak
Clinical Pearl: This is why a delayed Heart Rate Recovery (e.g., a drop of <12 bpm in the first minute of active recovery) is such a strong independent predictor of cardiovascular mortality. It tells you plain as day that the patient's parasympathetic "brakes" are impaired or their sympathetic system is locked in overdrive.
The Big Picture
It's pretty incredible to think about—every shift in the O₂ pulse, every inflection point on a Wasserman 9-panel plot, and every leap in ventilation is fundamentally a reflection of this elegant autonomic transition.
Reading the Wasserman 9-Panel Plot in Children: Why Kids Aren't Small Adults
Nine graphs on a single page. The way through is to stop treating it as nine separate graphs and start treating it as one story told from nine angles — a story that unfolds in time, and one whose grammar is different in paediatrics.
For anyone learning cardiopulmonary exercise testing, the Wasserman 9-panel plot is simultaneously the most useful and the most intimidating thing in the report. It compresses fifteen or more variables into one visual field, and the temptation is to stare at all of it at once and absorb none of it.
The way through is to treat it as a single physiological narrative — one that begins before the child does any work at all, and doesn't finish when they stop.
The story has six chapters, not one
Most explanations of the 9-panel plot jump straight to the ramp. But a CPET has a shape, and every phase of it is diagnostic.
Rest. The child sits on the ergometer, mask on, doing nothing. This is baseline, and it matters more than people credit. Resting heart rate in children runs considerably higher than in adults — often around 80 bpm rather than 60 — and resting respiratory rate is higher too. RER sits around 0.8, reflecting a fat-predominant substrate mix. If the baseline is odd, everything downstream is harder to interpret.
Unloaded warm-up. The child pedals against no resistance. Work rate is still zero, but metabolism has already climbed above rest: V̇O₂ rises to a new steady state, heart rate lifts, breathing deepens. This phase is not filler. It establishes the anchor from which the ΔV̇O₂/ΔWR slope is measured on Panel 3 — the efficiency with which the child converts work into oxygen uptake.
The incremental ramp. Work rate climbs progressively. V̇O₂ and V̇CO₂ rise together, heart rate climbs roughly linearly, ventilation increases in step with CO₂ production. Everything is orderly, and it stays orderly until the first threshold.
The anaerobic threshold (VT₁). Lactate begins to accumulate. Bicarbonate buffers the resulting hydrogen ions, and that buffering reaction liberates additional CO₂ — CO₂ that has nothing to do with aerobic metabolism. This is the single most important mechanism in the whole test, because it explains almost everything you see next.
Once you understand that bicarbonate buffering releases extra CO₂, the V-slope inflection, the RER crossing, the ventilatory equivalent divergence and the end-tidal changes stop being four facts to memorise and become four views of one event.
Peak. The child stops. Heart rate is near maximum, ventilation has surged, RER exceeds 1.0.
Recovery. This is the chapter most teaching tools omit entirely, and it is quietly one of the most informative. When work stops, gas exchange does not simply reverse. V̇O₂ falls fastest as the oxygen deficit is repaid. V̇CO₂ and V̇E lag behind, because buffered CO₂ is still washing out of the blood. The consequence is counterintuitive and worth sitting with: RER transiently rises after exercise stops, often above its peak-exercise value, before falling below baseline. Heart rate recovers slowest of all, and the magnitude of its fall in the first minute reflects vagal reactivation.
Interactive
Walk through a complete paediatric CPET
Drag the timeline from rest through warm-up, the ramp, the anaerobic threshold, peak and into recovery. Watch the heart, lungs and muscles respond on the left while all nine Wasserman panels populate on the right. Recovery points appear as purple triangles.
Rest: Basal metabolic demand. Children run a higher resting HR (~80 bpm) and respiratory rate (~22 br/min) than adults. RER ~0.82, low V̇E. All Wasserman variables at baseline.
Illustrative healthy pediatric model — not a normative calculatorProtocol phases: Rest → unloaded warm-up → incremental ramp → AT (VT₁) → peak → recovery. The dashed line marks the AT once crossed.
Typical peak HR ≈175–200 bpm ·
Peak RER ≈1.00–1.10 ·
V̇E/V̇CO₂ nadir higher than adults ·
Treadmill → higher peak values than cycle
This tool demonstrates the shape and direction of the nine Wasserman curves through a complete test, using values representative of a healthy child/adolescent. It is not a source of reference values for individual interpretation. Peak V̇O₂, work rate and tidal volumes scale strongly with body size, sex, maturation and test modality — always interpret a real study against reference equations derived from a cohort matching your patient. Note that AT expressed as a percentage of peak V̇O₂ declines with age across childhood, so a single fixed percentage cannot represent the whole 8–17 range.
Reading the nine panels in order
The canonical Wasserman sequence is not arbitrary — it moves from ventilation, through the cardiovascular system, to gas exchange, and each panel answers a specific question.
Plot
The question it answers
1
V̇E vs work rate
How much ventilation is this workload costing?
2
HR and O₂ pulse vs work rate
Is the cardiovascular response appropriate?
3
V̇O₂ and V̇CO₂ vs work rate
Is work being converted to oxygen uptake efficiently?
4
V̇E vs V̇CO₂
Is ventilation matched to CO₂ production?
5
V̇CO₂ and HR vs V̇O₂
The V-slope — where is the AT?
6
V̇E/V̇O₂ and V̇E/V̇CO₂ vs work rate
Confirming the thresholds
7
Tidal volume vs V̇E
How is the breathing pattern constructed?
8
RER vs work rate
Was the effort maximal?
9
PetO₂ and PetCO₂ vs work rate
Corroborating thresholds from gas tensions
Panel 5 is the one to learn first. The V-slope method — plotting V̇CO₂ against V̇O₂ and finding where the relationship breaks from unity — is the primary way the anaerobic threshold is identified. Panels 6 and 9 exist largely to corroborate what Panel 5 suggests. When the three agree, you have a threshold you can defend.
Panel 8 answers a different question: not what happened but can I trust this test at all. A peak RER comfortably above 1.0 supports a maximal effort.
Where paediatrics diverges
Here is where transplanting adult intuition goes wrong.
Children are metabolically different, not just smaller
Pre-pubertal children rely more heavily on oxidative metabolism and have a diminished anaerobic capacity relative to adults. Proposed mechanisms include reduced recruitment of the large motor units innervating type II fibres, higher oxidative enzyme activity, and greater mitochondrial density. The practical consequence is that children reach their ventilatory thresholds at higher body-mass-adjusted V̇O₂ values than moderately trained adults — a child's metabolic profile has genuine similarities to a trained endurance adult's.
They ventilate more for the same CO₂
Children require greater ventilation to clear CO₂ and maintain their arterial CO₂ set point, which is why ventilatory equivalents run higher and absolute oxygen uptake efficiency runs lower than in adults. Applying an adult V̇E/V̇CO₂ cut-off to a child will systematically mislabel normal physiology as inefficiency.
Peak heart rate is higher and behaves differently
Peak heart rates in the high 190s are normal. More importantly, in young people peak heart rate is largely individually determined, and the demographic effects — age above all — that make adult HRmax prediction equations workable are far weaker in children.
Maximal effort is harder to prove
This is the uncomfortable one. There are no validated secondary exhaustion criteria for children. The commonly applied threshold is simply HRmax ≥ 95% of 195 bpm, and the criteria in general are acknowledged in the literature to be arbitrary rather than data-driven. Children also demonstrate V̇O₂ plateaus less frequently than adults, plausibly because of their lower anaerobic capacity — so the plateau-based criteria that anchor adult interpretation don't transfer. Add ordinary variation in a child's motivation and cooperation, and peak values in paediatrics are inherently softer than the equivalent adult numbers.
The reference-value problem, stated honestly
This is the part most likely to be got wrong — including by tools and explainers that project more confidence than the evidence supports.
Normative paediatric CPET data vary substantially between cohorts. Published peak V̇O₂ values span a very wide range once you include both sexes, the full age span, and athletic versus general-population children. Methodology compounds this: treadmill testing yields higher peak V̇O₂, peak heart rate and peak ventilation than cycle ergometry, so a value that is normal on one ergometer may look borderline on the other. Beyond peak V̇O₂ and peak heart rate, reporting thins out quickly — peak ventilation is reported far less often, and VT₂ has barely been studied in children at all.
One trap deserves naming
The anaerobic threshold expressed as a percentage of peak V̇O₂ declines with age through childhood. Younger children reach VT₁ at a higher proportion of their peak than adolescents do. This means any single figure — “the AT sits at 60% of peak” — cannot honestly describe an 8-to-17-year-old range. An 8-year-old and a 17-year-old are at genuinely different points on that curve.
The defensible position is the one the systematic reviews themselves reach: select reference values derived from a cohort that matches your patient in age, sex, body size, activity level and testing modality. A number without its cohort attached is not a reference value; it is a guess with a decimal point.
What this means for teaching
If you are teaching the 9-panel plot — to trainees, to colleagues, or to yourself — a few things help.
Teach the mechanism before the pattern. Once someone genuinely understands that bicarbonate buffering releases extra CO₂, four separate facts collapse into one event seen from four angles.
Teach the phases, including recovery. A test is a trajectory, not a peak value.
Teach Panel 5 first, then use 6 and 9 to confirm it. Nine panels at once is how people learn to feel overwhelmed; two panels and a mechanism is how they learn to read a report.
And teach the caveats alongside the numbers. In paediatrics especially, knowing why a reference value might not apply to the child in front of you is not a footnote to competence. It is the competence.
